10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 2, 2020

or

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to    

Commission File Number: 001-36341        

Vectrus, Inc.

(Exact name of registrant as specified in its charter)

Indiana			38-3924636
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
2424 Garden of the Gods Road,	Colorado Springs,	Colorado	80919
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code:
(719)	591-3600

Securities Registered Under Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, Par Value $0.01 Per Share	VEC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☑   No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☑    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☑	Non-accelerated filer	☐
Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐

No  ☑

As of November 6, 2020, there were 11,624,568 shares of common stock ($0.01 par value per share) outstanding.

VECTRUS, INC.

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page No.
	PART I. FINANCIAL INFORMATION	4
Item 1.	Financial Statements	4
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Balance Sheets	6
	Condensed Consolidated Statements of Cash Flows	7
	Condensed Consolidated Statements of Changes to Shareholders' Equity	8
	Note 1. Description of Business and Summary of Significant Accounting Policies	10
	Note 2. Recent Accounting Standards Update	12
	Note 3. Revenue	13
	Note 4. Income Taxes	16
	Note 5. Acquisitions	16
	Note 6. Goodwill and Intangible Assets	17
	Note 7. Earnings Per Share	18
	Note 8. Receivables	18
	Note 9. Debt	19
	Note 10. Derivative Instruments	20
	Note 11. Leases	21
	Note 12. Stock-based Compensation	22
	Note 13. Commitments and Contingencies	23
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	32
Item 4.	Controls and Procedures	33
	PART II. OTHER INFORMATION	34
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	Defaults upon Senior Securities	35
Item 4.	Mine Safety Disclosures	35
Item 5.	Other Information	35
Item 6.	Exhibits	35
	Signatures	35

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

VECTRUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

	Three Months Ended				Nine Months Ended
	October 2,		September 27,		October 2,		September 27,
(In thousands, except per share data)	2020		2019		2020		2019
Revenue	$	352,415	$	359,873	$	1,040,212	$	1,017,368
Cost of revenue	320,234		327,523		951,743		923,671
Selling, general, and administrative expenses	17,344		19,934		58,718		59,697
Operating income	14,837		12,416		29,751		34,000
Interest expense, net	(939)		(1,907)		(3,988)		(4,811)
Income from operations before income taxes	13,898		10,509		25,763		29,189
Income tax expense	3,507		2,668		5,593		6,657
Net income	$	10,391	$	7,841	$	20,170	$	22,532
Earnings per share
Basic	$	0.89	$	0.68	$	1.74	$	1.97
Diluted	$	0.88	$	0.67	$	1.72	$	1.95
Weighted average common shares outstanding - basic	11,621		11,506		11,590		11,420
Weighted average common shares outstanding - diluted	11,751		11,678		11,743		11,566

The accompanying notes are an integral part of these financial statements.

4

VECTRUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

	Three Months Ended				Nine Months Ended
	October 2,		September 27,		October 2,		September 27,
(In thousands)	2020		2019		2020		2019
Net income	$	10,391	$	7,841	$	20,170	$	22,532
Other comprehensive income (loss), net of tax
Changes in derivative instruments:
Net change in fair value of interest rate swap	290		(194)		(1,035)		(1,570)
Net change in fair value of foreign currency forward contracts	204		(207)		338		(123)
Net (loss) gain reclassified to interest expense	—		(8)		—		43
Tax (expense) benefit	(202)		88		56		357
Net change in derivative instruments	292		(321)		(641)		(1,293)
Foreign currency translation adjustments, net of tax	2,042		(1,526)		2,578		(1,801)
Accounting Standards Update (ASU) 2018-02 reclassification of certain tax effects to Retained Earnings	—		—		—		(259)
Other comprehensive income (loss), net of tax	2,334		(1,847)		1,937		(3,353)
Total comprehensive income	$	12,725	$	5,994	$	22,107	$	19,179

The accompanying notes are an integral part of these financial statements.

5

VECTRUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

	October 2,		December 31,
(In thousands, except share information)	2020		2019
Assets
Current assets
Cash	$	63,734	$	35,318
Receivables	268,143		269,144
Other current assets	24,537		16,154
Total current assets	356,414		320,616
Property, plant, and equipment, net	19,256		18,844
Goodwill	262,130		261,983
Intangible assets, net	11,902		14,926
Right-of-use assets	9,970		14,654
Other non-current assets	6,256		5,366
Total non-current assets	309,514		315,773
Total Assets	$	665,928	$	636,389
Liabilities and Shareholders' Equity
Current liabilities
Accounts payable	$	146,458	$	148,015
Compensation and other employee benefits	54,216		53,155
Short-term debt	8,000		6,500
Other accrued liabilities	38,572		37,409
Total current liabilities	247,246		245,079
Long-term debt, net	57,326		63,041
Deferred tax liability	41,734		49,407
Other non-current liabilities	35,817		19,997
Total non-current liabilities	134,877		132,445
Total liabilities	382,123		377,524
Commitments and contingencies (Note 13)
Shareholders' Equity
Preferred stock; $0.01 par value; 10,000,000 shares authorized; No shares issued and outstanding	—		—
Common stock; $0.01 par value; 100,000,000 shares authorized; 11,621,709 and 11,523,691 shares issued and outstanding as of October 2, 2020 and December 31, 2019, respectively	116		115
Additional paid in capital	81,589		78,757
Retained earnings	205,245		185,075
Accumulated other comprehensive loss	(3,145)		(5,082)
Total shareholders' equity	283,805		258,865
Total Liabilities and Shareholders' Equity	$	665,928	$	636,389

The accompanying notes are an integral part of these financial statements.

6

VECTRUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

	Nine Months Ended
	October 2,		September 27,
(In thousands)	2020		2019
Operating activities
Net income	$	20,170	$	22,532
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense	3,001		2,395
Amortization of intangible assets	3,031		2,103
Loss on disposal of property, plant, and equipment	63		2
Stock-based compensation	6,499		5,952
Amortization of debt issuance costs	286		301
Changes in assets and liabilities:
Receivables	3,584		(7,540)
Other assets	(8,826)		(5,820)
Accounts payable	(1,988)		(14,458)
Deferred taxes	(7,575)		(4,670)
Compensation and other employee benefits	813		17,863
Other liabilities	18,597		9,788
Net cash provided by operating activities	37,655		28,448
Investing activities
Purchases of capital assets and intangibles	(3,348)		(14,440)
Proceeds from the disposition of assets	—		5,400
Acquisition of business, net of cash acquired	—		(43,963)
Net cash (used in) investing activities	(3,348)		(53,003)
Financing activities
Repayments of long-term debt	(4,500)		(2,000)
Proceeds from revolver	151,000		226,000
Repayments of revolver	(151,000)		(226,000)
Proceeds from exercise of stock options	59		3,467
Payments of employee withholding taxes on share-based compensation	(1,918)		(768)
Net cash (used in) provided by financing activities	(6,359)		699
Exchange rate effect on cash	468		(1,239)
Net change in cash	28,416		(25,095)
Cash-beginning of year	35,318		66,145
Cash-end of period	$	63,734	$	41,050
Supplemental disclosure of cash flow information:
Interest paid	$	3,030	$	4,363
Income taxes paid	$	12,570	$	5,076
Non-cash investing activities:
Purchase of capital assets on account	$	373	$	394

The accompanying notes are an integral part of these financial statements.

7

VECTRUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES TO SHAREHOLDERS' EQUITY (UNAUDITED)

	Common Stock Issued			Additional Paid-in Capital				Accumulated Other Comprehensive Loss		Total Shareholders' Equity
(In thousands)	Shares	Amount				Retained Earnings
Balance at December 31, 2018	11,267	$	113	$	71,729	$	151,640	$	(3,158)	$	220,324
Net income						7,074				7,074
Cumulative effects of adoption of ASU 2018-02 reclassification of certain tax effects from AOCI						259		(259)		—
Foreign currency translation adjustments								(823)		(823)
Unrealized loss on cash flow hedge								(360)		(360)
Employee stock awards and stock options	85	1		601						602
Taxes withheld on restricted stock unit compensation awards				(683)						(683)
Stock-based compensation				1,117						1,117
Balance at March 29, 2019	11,352	$	114	$	72,764	$	158,973	$	(4,600)	$	227,251
Net income						7,617				7,617
Foreign currency translation adjustments								547		547
Unrealized loss on cash flow hedge								(611)		(611)
Employee stock awards and stock options	154	1		2,864						2,865
Taxes withheld on restricted stock unit compensation awards				(85)						(85)
Stock-based compensation				1,099						1,099
Balance at June 28, 2019	11,506	$	115	$	76,642	$	166,590	$	(4,664)	$	238,683
Net income						7,841				7,841
Foreign currency translation adjustments								(1,526)		(1,526)
Unrealized loss on cash flow hedge								(321)		(321)
Stock-based compensation				1,124						1,124
Balance at September 27, 2019	11,506	$	115	$	77,766	$	174,431	$	(6,511)	$	245,801
Balance at December 31, 2019	11,524	$	115	$	78,757	$	185,075	$	(5,082)	$	258,865
Net income						8,668				8,668
Foreign currency translation adjustments								(1,934)		(1,934)
Unrealized loss on cash flow hedge								(1,290)		(1,290)
Employee stock awards and stock options	64	1		—						1
Taxes withheld on stock compensation awards				(1,787)						(1,787)
Stock-based compensation				1,720						1,720
Balance at April 3, 2020	11,588	$	116	$	78,690	$	193,743	$	(8,306)	$	264,243
Net income						1,111				1,111
Foreign currency translation adjustments								2,470		2,470
Unrealized gain on cash flow hedge								357		357

8

Employee stock awards and stock options	32	—		58						58
Taxes withheld on restricted stock unit compensation awards				(86)						(86)
Stock-based compensation				1,282						1,282
Balance at July 3, 2020	11,620	$	116	$	79,944	$	194,854	$	(5,479)	$	269,435
Net income						10,391				10,391
Foreign currency translation adjustments								2,042		2,042
Unrealized gain on cash flow hedge								292		292
Employee stock awards and stock options	2	—		—						—
Conversion of liability-based stock compensation awards to equity-based stock compensation awards				405						405
Taxes withheld on restricted stock unit compensation awards				(44)						(44)
Stock-based compensation				1,284						1,284
Balance at October 2, 2020	11,622	$	116	$	81,589	$	205,245	$	(3,145)	$	283,805

The accompanying notes are an integral part of these financial statements.

9

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of Business and Basis of Presentation

Our Business

    Vectrus, Inc. is a leading provider of services to the United States Government (U.S. Government) worldwide. The Company operates as one segment and provides the following services and offerings: facility and base operations; supply chain and logistics services; information technology mission support; and engineering and digital technology services.

    Vectrus was incorporated in the State of Indiana on February 4, 2014. On September 27, 2014, Exelis Inc. (Exelis) completed a spin-off (the Spin-off) of Vectrus, and Vectrus became an independent, publicly traded company. Unless the context otherwise requires, references in these notes to "Vectrus", "we," "us," "our," "the Company" and "our Company" refer to Vectrus, Inc. References in these notes to Exelis or "Former Parent" refer to Exelis Inc. and its consolidated subsidiaries (other than Vectrus) or successor entities.

Basis of Presentation

    Our quarterly financial periods end on the Friday closest to the last day of the calendar quarter (October 2, 2020 for the third quarter of 2020 and September 27, 2019 for the third quarter of 2019), except for the last quarter of the fiscal year, which ends on December 31. For ease of presentation, the quarterly financial statements included herein are described as three months ended.

    The unaudited interim Condensed Consolidated Financial Statements of Vectrus have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been omitted. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019.

    It is management’s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the Company’s financial position and operating results. Revenue and net income for any interim period are not necessarily indicative of future or annual results.

Immaterial Restatement of Prior Period Balances

    Subsequent to the issuance of our Annual Report on Form 10-K for the year ended December 31, 2019, we identified an error in our historical financial statements related to estimated contract costs for the year ended December 31, 2019 as well as an error in our historical financial statements related to overbilling for a separate contract dating back to 2013, prior to the Spin-off. In the first instance, management determined that additional subcontractor costs should have been included as part of estimated contract costs, resulting in a misstatement in other accrued liabilities and cost of revenue as well as revenue and accounts receivable to a lesser extent. In the second instance, management identified that certain contract costs were incorrectly included in customer billings for one contract, resulting in a misstatement in revenue and other accrued liabilities.

    The cumulative impact of the errors was a $2.5 million decrease in retained earnings as of December 31, 2019. The impact of the errors on net income for the year ended December 31, 2019 is $1.5 million. The impact on diluted earnings per share is a decrease of $0.13 for the year ended December 31, 2019. The impact to diluted earnings per share in the first, second, third, and fourth quarters of 2019 is a decrease of $0.00, $0.00, $0.13, and $0.00, respectively. The impact on diluted earnings per share is a decrease of $0.02 and $0.01 for the years ended December 31, 2018 and 2017, respectively. 

    Accordingly, the Company is restating the relevant financial statements and related footnotes for all applicable periods for these errors and related tax effect and will correct the respective financial statements as they appear in future filings. Management has evaluated the materiality of these misstatements and concluded they were not material to prior periods, individually or in aggregate.

10

    The effects of the corrections to each of the individual affected line items in our Condensed Consolidated Statements of Income were as follows:

	Three Months Ended September 27, 2019						Nine Months Ended September 27, 2019
(In thousands, except per share data)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Revenue	$	359,854	$	19	$	359,873	$	1,017,371	$	(3)	$	1,017,368
Cost of revenue	325,537		1,986		327,523		921,685		1,986		923,671
Operating income	14,383		(1,967)		12,416		35,989		(1,989)		34,000
Income from operations before income taxes	12,476		(1,967)		10,509		31,178		(1,989)		29,189
Income tax expense	3,094		(426)		2,668		7,088		(431)		6,657
Net income	$	9,382	$	(1,541)	$	7,841	$	24,090	$	(1,558)	$	22,532
Earnings per share
Basic	$	0.82	$	(0.14)	$	0.68	$	2.11	$	(0.14)	$	1.97
Diluted	$	0.80	$	(0.13)	$	0.67	$	2.08	$	(0.13)	$	1.95

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Comprehensive Income were as follows:

	Three Months Ended September 27, 2019						Nine Months Ended September 27, 2019
(In thousands)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Net income	$	9,382	$	(1,541)	$	7,841	$	24,090	$	(1,558)	$	22,532
Total comprehensive income	$	7,535	$	(1,541)	$	5,994	$	20,737	$	(1,558)	$	19,179

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Balance Sheet were as follows:

	December 31, 2019
(In thousands)	As Previously Reported		Correction		As Corrected
Receivables	$	269,239	$	(95)	$	269,144
Total current assets	320,711		(95)		320,616
Total Assets	636,484		(95)		636,389
Other accrued liabilities	34,587		2,822		37,409
Total current liabilities	242,257		2,822		245,079
Deferred tax liability	49,808		(401)		49,407
Total non-current liabilities	132,846		(401)		132,445
Total Liabilities	375,103		2,421		377,524
Retained earnings	187,591		(2,516)		185,075
Total shareholders' equity	261,381		(2,516)		258,865
Total Liabilities and Shareholders' Equity	$	636,484	$	(95)	$	636,389

11

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Cash Flows were as follows:

	Nine Months Ended September 27, 2019
(In thousands)	As Previously Reported		Correction		As Corrected
Net income	$	24,090	$	(1,558)	$	22,532
Changes in receivables	(7,521)		(19)		(7,540)
Changes in deferred taxes	(4,240)		(430)		(4,670)
Changes in other liabilities	7,781		2,007		9,788
Net cash provided in operating activities	$	28,448	$	—	$	28,448

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Changes in Shareholders' Equity were as follows:

	Retained Earnings						Total Shareholders' Equity
(In thousands)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Balance at December 31, 2018	$	152,616	$	(976)	$	151,640	$	221,300	$	(976)	$	220,324
Net income	7,091		(17)		7,074		7,091		(17)		7,074
Balance at March 29, 2019	159,966		(993)		158,973		228,244		(993)		227,251
Net income	7,617		—		7,617		7,617		—		7,617
Balance at June 28, 2019	167,583		(993)		166,590		239,676		(993)		238,683
Net income	9,382		(1,541)		7,841		9,382		(1,541)		7,841
Balance at September 27, 2019	$	176,965	$	(2,534)	$	174,431	$	248,335	$	(2,534)	$	245,801

NOTE 2

RECENT ACCOUNTING STANDARDS UPDATE

Accounting Standards Issued but Not Yet Effective

    In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes (ASU 2019-12). The objectives of ASU 2019-12 are (i) to simplify the accounting for income taxes by removing certain exceptions, (ii) to update certain requirements to simplify the accounting for income taxes, and (iii) to make minor codification improvements for income taxes. The guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the adoption of this standard to have a material impact on the Company’s financial statements.

Accounting Standards That Were Adopted

    In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) (ASU 2018-15). The objective of ASU 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with those incurred to develop or obtain internal-use software. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The amendments can be applied either retrospectively or prospectively. We adopted ASU 2018-15 on January 1, 2020 using the retrospective method. As a result of the adoption, $0.3 million was reclassified from 2019 year-end property, plant and equipment, net, to other non-current assets on our Condensed Consolidated Balance Sheet. In addition, $0.3 million of cash outflows from investing activities incurred during the third and fourth quarters of 2019 was reclassified to cash outflows from operating activities.

    In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (ASU 2017-04). The objective of ASU 2017-04 is to simplify the subsequent measurement of goodwill by entities performing their annual goodwill impairment tests by comparing the fair value of a reporting unit, including income tax effects from any tax-deductible goodwill, with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds fair value. ASU 2017-04 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2017-04 should be applied on a prospective basis. We adopted ASU 2017-04 on January 1, 2020.  The adoption of the standard did not have a material impact on our financial statements.    

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with more useful information about the expected credit losses

12

on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. We adopted the standard on January 1, 2020. The adoption of the standard did not have a material impact on our financial statements.

NOTE 3

REVENUE

Performance Obligations

    A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account for revenue in ASC Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. To determine the proper revenue recognition method, consideration is given as to whether a single contract should be accounted for as more than one performance obligation. For most of our contracts, the customer contracts with us to perform an integrated set of tasks and deliverables as a single service solution, whereby each service is not separately identifiable from other promises in the contract and therefore is not distinct. As a result, when this integrated set of tasks exists, the contract is accounted for as one performance obligation. The vast majority of our contracts have a single performance obligation. Unexercised contract options and indefinite delivery and indefinite quantity (IDIQ) contracts are considered to be separate performance obligations when the option or IDIQ task order is exercised or awarded.

    Contract modifications are routine in the performance of our contracts. Contracts are often modified to account for changes in contract specifications or requirements. In most instances, contract modifications are for goods or services that are not distinct, and therefore, are accounted for as part of the existing contract. Modifications to exercise option years create new enforceable rights and obligations and therefore are treated as separate performance obligations.

    The Company's performance obligations are typically satisfied over time as services are provided throughout the contract term. We recognize revenue over time using the input method (e.g., costs incurred to date relative to total estimated costs at completion) to measure progress. Our over time recognition is reinforced by the fact that our customers simultaneously receive and consume the benefits of our services as they are performed. This continuous transfer of control requires that we track progress towards completion of performance obligations in order to measure and recognize revenue. Determining progress on performance obligations requires us to make judgments that affect the timing of revenue recognition. Remaining performance obligations represent firm orders by the customer and excludes potential orders under IDIQ contracts, unexercised contract options, and contracts awarded to us that are being protested by competitors with the U.S. Government Accountability Office (GAO) or in the U.S. Court of Federal Claims. The level of order activity related to contracts can be affected by the timing of government funding authorizations and their project evaluation cycles. Year-over-year comparisons could, at times, be impacted by these factors, among others.

    The Company's contracts are multi-year contracts and typically include an initial period of one year or less with annual one-year (or less) option periods. The number of option periods varies by contract, and there is no guarantee that an option period will be exercised. The right to exercise an option period is at the sole discretion of the U.S. Government when we are the prime contractor or of the prime contractor when we are a subcontractor. We expect to recognize a substantial portion of our performance obligations as revenue within the next 12 months. However, the U.S. Government or the prime contractor may cancel any contract at any time through a termination for convenience or for cause. Substantially all of our contracts have terms that would permit us to recover all or a portion of our incurred costs and fees for work performed in the event of a termination for convenience.

13

    Remaining performance obligations increased by $306.4 million as of October 2, 2020 as compared to December 31, 2019. We expect to recognize approximately 30% of the remaining performance obligations as of October 2, 2020 as revenue in 2020, and the remaining 70% during 2021. Remaining performance obligations as of October 2, 2020 and December 31, 2019 are presented in the following table:

	October 2,		December 31,
(In thousands)	2020		2019
Performance Obligations	$	1,155,742	$	849,389

Contract Estimates

    Accounting for contracts involves the use of various techniques to estimate total contract revenue and costs. We estimate the profit on our contracts as the difference between the total estimated revenue and expected costs to complete a contract and recognize that profit over the life of the contract.

    Contract estimates are based on various assumptions to project the outcome of future events. These assumptions include labor productivity and availability; the complexity of the services being performed; the cost and availability of materials; the performance of subcontractors; and the availability and timing of funding from the customer.

    The impact of adjustments in contract estimates on our operating income can be reflected in either revenue or cost of revenue. Cumulative catch-up adjustments for the three and nine months ended October 2, 2020 were favorable to operating income by less than $0.1 million and unfavorable to operating income by $3.8 million, respectively. For the three and nine months ended September 27, 2019, the net favorable adjustments to operating income were $0.7 million and $1.5 million, respectively.

    For the three and nine months ended October 2, 2020 the cumulative catch-up adjustments to operating income decreased revenue by $1.1 million and $0.5 million, respectively. For the three and nine months ended September 27, 2019, the cumulative catch-up adjustments to operating income increased revenue by $4.0 million and $4.2 million, respectively.

Revenue by Category

    Generally, the sales price elements for our contracts are cost-plus, cost-reimbursable or firm-fixed-price. We commonly have elements of cost-plus, cost-reimbursable and firm-fixed-price contracts on a single contract. On a cost-plus type contract, we are paid our allowable incurred costs plus a profit, which can be fixed or variable depending on the contract’s fee arrangement, up to funding levels predetermined by our customers. On cost-plus type contracts, we do not bear the risks of unexpected cost overruns, provided that we do not incur costs that exceed the predetermined funded amounts. Cost-plus type contracts with award and incentive fee provisions are our primary variable contract fee arrangement. Award fees provide for a fee based on actual performance relative to contractually specified performance criteria. Incentive fees provide for a fee based on the relationship between total allowable and target cost. On most of our contracts, a cost-reimbursable element captures consumable materials required for the contract. Typically, these costs do not bear fees.

    On a firm-fixed-price type contract, we agree to perform the contractual statement of work for a predetermined contract price. A firm-fixed-price type contract typically offers higher profit margin potential than a cost-plus type contract, which is commensurate with the greater levels of risk we assume on a firm-fixed-price type contract. Although a firm-fixed-price type contract generally permits us to retain profits if the total actual contract costs are less than the estimated contract costs, we bear the risk that increased or unexpected costs may reduce our profit or cause us to sustain losses on the contract. Although the overall scope of work required under the contract may not change, profit may be adjusted as experience is gained and as efficiencies are realized or costs are incurred.

    The following tables present our revenue disaggregated by several categories. Revenue by contract type for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Cost-plus and cost-reimbursable ¹	$	249,484	$	272,810	(8.6)	%	$	748,543	$	781,024	(4.2)	%
Firm-fixed-price	102,931		87,063		18.2	%	291,669		236,344		23.4	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368
¹ Includes time and material contracts

14

    Revenue by geographic region in which the contract is performed for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Middle East	$	224,934	$	244,142	(7.9)	%	$	679,633	$	695,626	(2.3)	%
United States	89,400		77,228		15.8	%	254,640		219,512		16.0	%
Europe	38,081		38,503		(1.1)	%	105,939		102,230		3.6	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

    Revenue by contract relationship for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Prime contractor	$	332,564	$	334,402	(0.5)	%	$	980,301	$	954,191	2.7	%
Subcontractor	19,851		25,471		(22.1)	%	59,911		63,177		(5.2)	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

    Revenue by customer for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2.		September 27,		%		October 2.		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Army	$	236,267	$	245,817	(3.9)	%	$	711,173	$	698,377	1.8	%
Air Force	79,425		86,576		(8.3)	%	231,088		227,100		1.8	%
Navy	18,785		13,344		40.8	%	48,564		45,227		7.4	%
Other	17,938		14,136		26.9	%	49,387		46,664		5.8	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

Contract Balances

    The timing of revenue recognition, billings and cash collections results in billed and unbilled accounts receivable (contract assets) and customer advances and deposits (contract liabilities) on the Condensed Consolidated Balance Sheets. Amounts are billed as work progresses in accordance with agreed-upon contractual terms at periodic intervals (e.g., biweekly or monthly). Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. However, we may receive advances or deposits from our customers, before revenue is recognized, resulting in contract liabilities. These advance billings and payments are not considered significant financing components because they are frequently intended to ensure that both parties are in conformance with the primary contract terms. These assets and liabilities are reported on the Condensed Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period.

    As of October 2, 2020 and December 31, 2019, we had contract assets of $199.3 million and $186.4 million, respectively. Refer to Note 8, "Receivables" for additional information regarding the composition of our receivable balances. As of both October 2, 2020 and December 31, 2019, our contract liabilities were insignificant.

15

NOTE 4

INCOME TAXES

Effective Tax Rate

    Income tax expense during interim periods is based on an estimated annual effective income tax rate, plus any significant unusual or infrequently occurring items recorded in interim periods. The computation of the estimated effective income tax rate at each interim period requires certain estimates and judgment including, but not limited to, forecasted operating income for the year, projections of the income earned and taxed in various jurisdictions, newly enacted tax rate and legislative changes, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year.

    For the quarters ended October 2, 2020 and September 27, 2019, we recorded an income tax provision of $3.5 million and $2.7 million, respectively, representing effective income tax rates of 25.2% and 25.4%. For the nine months ended October 2, 2020 and September 27, 2019, we recorded income tax provisions of $5.6 million and $6.7 million, representing effective income tax rates of 21.7% and 22.8%, respectively. The effective income tax rates vary from the federal statutory rate of 21.0% due to state and foreign taxes, required tax income exclusions, nondeductible expenses and available deductions not reflected in book income.

Uncertain Tax Provisions

    As of October 2, 2020, and December 31, 2019, unrecognized tax benefits from uncertain tax positions were $12.5 million and $7.9 million, respectively. The increase in the uncertain tax positions was principally the result of the additional Foreign Derived Intangible Income (FDII) deduction.

NOTE 5

ACQUISITIONS

Advantor

    On July 8, 2019, we acquired Advantor from Infrasafe Holding, Inc. and Infrasafe, LLC (collectively, Infrasafe). Advantor is a leading provider of integrated electronic security systems to the U.S. Government. In accordance with ASC Topic 805, Business Combinations, we accounted for this transaction using the acquisition method. We conducted valuations of certain acquired assets and liabilities for inclusion in our Condensed Consolidated Balance Sheets as of the date of acquisition. Assets that normally would not be recorded in ordinary operations (i.e. intangibles related to contractual relationships) were recorded at their estimated fair values. The excess purchase price over the estimated fair value of the net assets acquired was recorded as goodwill.

    The total net consideration paid for the acquisition was $45.1 million, consisting of the purchase price of $44.0 million, net of cash acquired, and $1.1 million for working capital in excess of the working capital requirement agreed upon in the stock purchase agreement. The acquisition was funded by utilizing cash on hand and available capacity from our Amended Revolver (as defined in Note 9, “Debt”).

    A breakdown of the purchase price allocation, net of cash acquired, is as follows:

(In thousands)	Allocation of Purchase Price
Receivables	$	11,388
Other current assets	2,719
Property, plant and equipment	155
Goodwill	28,511
Intangible assets	8,300
Other non-current assets	1,868
Accounts payable	(4,223)
Other current liabilities	(1,519)
Accrued compensation	(907)
Other non-current liabilities	(1,218)
Purchase price, net of cash acquired	$	45,074

    We completed purchase accounting for the acquisition as of July 3, 2020 with no material adjustments. The Company recognized two intangible assets related to customer contracts (backlog) and the Advantor trade name arising from the acquisition. The fair value of the customer contracts was $7.2 million, and the fair value of the Advantor trade name was $1.1 million with amortization periods of 5.0 years and 4.5 years, respectively. As of October 2, 2020, the remaining weighted-average amortization period for these intangible assets was 3.7 years. The Company recorded amortization expense of $1.3

16

million during the first nine months of 2020. The amortization expense is included in cost of revenue in our Condensed Consolidated Statements of Income.

    Additionally, the Company recognized goodwill of $28.5 million arising from the acquisition, which relates primarily to acquired product and services strengthening our advance into a higher value, technology-enabled and differentiated platform, as well as extending our facilities and logistics services to include the electronic protection and security of facilities. Goodwill also includes other intangibles that do not qualify for separate recognition. The goodwill recognized for the Advantor acquisition is fully deductible for income tax purposes.

    Advantor's operating results have been included in our reported results since the date of acquisition.

NOTE 6

GOODWILL AND INTANGIBLE ASSETS

    As of October 2, 2020 and December 31, 2019 the carrying amount of goodwill was $262.1 million and $262.0 million, respectively. The $0.1 million increase during the first nine months of 2020 is due to a final adjustment to the Advantor purchase price allocation.

    The Company tests goodwill for impairment as of the beginning of the fourth quarter each year, or more frequently should circumstances change or events occur that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Due to the COVID-19 pandemic and the negative effect on the U.S. and global economy, the Company completed a qualitative assessment to evaluate whether or not it is more likely than not that the fair value of goodwill is less than its carrying amount. Based on our assessment of the totality of events and circumstances as of October 2, 2020, including the estimated impact of the COVID-19 pandemic on our business forecast and the Company's market capitalization, we determined that it is not more likely than not that the fair value of our reporting unit is below its carrying amount.

    Identifiable intangible assets consist of the following:

	October 2, 2020						December 31, 2019
(In thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Contract backlogs and recompetes	$	11,600	$	(6,053)	$	5,547	$	11,600	$	(4,300)	$	7,300
Customer contracts	7,200		(1,773)		5,427		7,200		(692)		6,508
Trade names and other	1,243		(315)		928		1,236		(118)		1,118
Balance	$	20,043	$	(8,141)	$	11,902	$	20,036	$	(5,110)	$	14,926

     Identifiable intangible asset amortization expense was $1.0 million and $3.0 million for the three and nine months ended October 2, 2020, respectively. Intangible amortization expense for the three and nine months ended September 27, 2019 was $0.8 million and $2.1 million, respectively. As of October 2, 2020, the remaining average intangible asset amortization period was 3.6 years.

    The estimated amortization expense for the next five years is as follows (in thousands):

Period	Amortization
2020 (excluding the nine months ended October 2, 2020)	$	998
2021	$	4,029
2022	$	2,501
2023	$	2,404
2024	$	1,297
After 2024	$	673

17

NOTE 7

EARNINGS PER SHARE

    Basic earnings per share (EPS) is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS reflects potential dilution that could occur if securities to issue common stock were exercised or converted into common stock. Diluted EPS includes the dilutive effect of stock-based compensation outstanding after application of the treasury stock method.

	Three Months Ended				Nine Months Ended
	October 2,		September 27,		October 2,		September 27,
(In thousands, except per share data)	2020		2019		2020		2019
Net income	$	10,391	$	7,841	$	20,170	$	22,532
Weighted average common shares outstanding	11,621		11,506		11,590		11,420
Add: Dilutive impact of stock options	34		37		38		45
Add: Dilutive impact of restricted stock units	96		135		115		101
Diluted weighted average common shares outstanding	11,751		11,678		11,743		11,566
Earnings per share
Basic	$	0.89	$	0.68	$	1.74	$	1.97
Diluted	$	0.88	$	0.67	$	1.72	$	1.95

    The following table provides a summary of securities that could potentially dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented:

	Three Months Ended		Nine Months Ended
	October 2,	September 27,	October 2,	September 27,
(In thousands)	2020	2019	2020	2019
Anti-dilutive stock options	—	—	—	1
Anti-dilutive restricted stock units	3	—	2	3
Total	3	—	2	4

NOTE 8

RECEIVABLES

    Receivables were comprised of the following:

(In thousands)	October 2, 2020		December 31, 2019
Billed receivables	$	59,445	$	71,068
Unbilled receivables (contract assets)	199,301		186,365
Other	9,397		11,711
Total receivables	$	268,143	$	269,144

    As of October 2, 2020 and December 31, 2019, substantially all billed receivables are due from the U.S. Government, either directly as prime contractor to the U.S. Government or as subcontractor to another prime contractor to the U.S. Government. Because our billed receivables are with the U.S. Government, we do not believe they represent a material credit risk exposure.

    Unbilled receivables are contract assets that represent revenue recognized on long-term contracts in excess of amounts billed as of the balance sheet date. We estimate that approximately $6.1 million of our unbilled receivables as of October 2, 2020 may not be collected within the next 12 months. These amounts relate to the timing of the U.S. Government review of indirect rates and contract line item realignments with our customers. Changes in the balance of receivables are primarily due to the timing differences between our performance and customers' payments.

18

NOTE 9

DEBT

Senior Secured Credit Facilities

    Term Loan and Revolver. In September 2014, we and our wholly-owned subsidiary, VSC, entered into a credit agreement with a group of lenders, including JPMorgan Chase Bank, N.A. as administrative agent. The credit agreement was subsequently amended in November 2017 by the Amendment and Restatement Agreement (the Amendment Agreement) with a group of lenders, including JPMorgan Chase Bank, N.A., as administrative agent. The Amendment Agreement provides for $200.0 million in senior secured financing, consisting of a $80.0 million five-year term loan facility (the Amended Term Loan) and a $120.0 million five-year senior secured revolving credit facility (the Amended Revolver, and together with the Amended Term Loan, the Amended Credit Facilities).

    Additionally, the Amendment Agreement includes an accordion feature that allows the Company to draw up to an additional $100.0 million, subject to the lender's consent. The Amendment Agreement also permits the Company to borrow up to $75.0 million in unsecured debt as long as the aggregated sum of both the unsecured debt and the accordion does not exceed $100.0 million.

    The Amended Revolver is available for working capital, capital expenditures, and other general corporate purposes. Up to $25.0 million of the Amended Revolver is available for the issuance of letters of credit. As of October 2, 2020, there were two letters of credit outstanding in the aggregate amount of $2.4 million, and no outstanding borrowings under the Amended Revolver resulting in borrowing capacity of $117.6 million under the Amended Revolver. The Amended Revolver will mature and the commitments thereunder will terminate on November 15, 2022.

    The aggregate scheduled maturities of the Amended Term Loan, are as follows:

(In thousands)	Payments due
2020 (excluding the nine months ended October 2, 2020)	$	2,000
2021	8,600
2022	55,400
Total	$	66,000

    Voluntary Prepayments. We may voluntarily prepay the Amended Term Loan in whole or in part at any time without premium or penalty, subject to the payment of customary breakage costs under certain conditions. Amounts borrowed under the Amended Term Loan that are repaid or prepaid may not be re-borrowed.

    Covenants. The Amended Credit Facilities contain customary covenants, including covenants that, under certain circumstances and subject to certain qualifications and exceptions: limit or restrict our ability to incur additional indebtedness; merge, dissolve, liquidate or consolidate; make acquisitions, investments, advances or loans; dispose of or transfer assets; pay dividends; redeem or repurchase certain debt; and enter into certain restrictive agreements.

    In addition, we are required to comply with (a) a maximum ratio of total consolidated indebtedness to consolidated earnings before interest, tax, depreciation and amortization (EBITDA) of 3.00 to 1.00 (3.25 to 1.00 for the 12 months following a qualified acquisition), and (b) a minimum ratio of consolidated EBITDA to consolidated interest expense (net of cash interest income) of 4.50 to 1.00. As of October 2, 2020, we had a ratio of total consolidated indebtedness to EBITDA of 0.99 to 1.00 and a ratio of consolidated EBITDA to consolidated interest expense of 12.60 to 1.00. We were in compliance with all covenants related to the Amended Credit Facilities as of October 2, 2020.

    Interest Rates and Fees. Outstanding borrowings under the Amended Credit Facilities accrue interest, at our option, at a per annum rate of (i) LIBOR plus the applicable margin, which ranges from 1.75% to 2.50% depending on the leverage ratio, or (ii) a base rate plus the applicable margin, which ranges from 0.75% to 1.50% depending on the leverage ratio. The interest rate under the Amended Credit Facilities at October 2, 2020 was 2.15%.

    Carrying Value and Fair Value. As of October 2, 2020 and December 31, 2019, the fair value of the Amended Credit Facilities approximated the carrying value because the debt bears interest at a floating rate of interest. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt.

19

NOTE 10

DERIVATIVE INSTRUMENTS

    During the periods covered by this report, we have made no changes to our policies or strategies for the use of derivative instruments and there has been no change in our related accounting methods. For our derivative instruments, which are designated as cash flow hedges, gains and losses are initially reported as a component of accumulated other comprehensive loss and subsequently recognized in earnings with the corresponding hedged item.

Interest Rate Derivative Instruments

    Our interest rate swaps are designated and qualify as effective cash flow hedges. The contracts, with expiration dates through November 2022 and notional amounts totaling $49.6 million at October 2, 2020, are recorded at fair value.

    The following table summarizes the amount at fair value and location of the derivative instruments in our balance sheet for our interest rate hedges in the Condensed Consolidated Balance Sheets as of October 2, 2020:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Interest rate swap designated as cash flow hedge	Other accrued liabilities	$	1,037
Interest rate swap designated as cash flow hedge	Other non-current liabilities	$	1,007

    The following table summarizes the amount at fair value and location of the derivative instruments used for our interest rate hedges in the Condensed Consolidated Balance Sheets as of December 31, 2019:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Interest rate swap designated as cash flow hedge	Other accrued liabilities	$	323
Interest rate swap designated as cash flow hedge	Other non-current liabilities	$	686

    We regularly assess the creditworthiness of the counterparty. As of October 2, 2020, the counterparty to the interest rate swaps had performed in accordance with its contractual obligations. Both the counterparty credit risk and our credit risk were considered in the fair value determination.

    Net interest rate derivative losses of $0.7 million and net interest rate derivative gains of less than $0.1 million were recognized in interest expense, net in our Condensed Consolidated Statements of Income during the first three quarters of 2020 and 2019, respectively. We expect $1.0 million of existing interest rate swap losses reported in accumulated other comprehensive loss as of October 2, 2020 to be recognized in earnings within the next 12 months.

Foreign Currency Derivative Instruments

    The following table summarizes the amount at fair value and location of the derivative instruments used for our forward contract hedges in the Condensed Consolidated Balance Sheets as of October 2, 2020:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Foreign currency forward designated as cash flow hedge	Other current assets	$	197
Foreign currency forward designated as cash flow hedge	Other accrued liabilities	$	44

    The following table summarizes the amount at fair value and location of the derivative instruments used for our forward contract hedges in the Condensed Consolidated Balance Sheets as of December 31, 2019:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Foreign currency forward designated as cash flow hedge	Other accrued liabilities	$	185

    At October 2, 2020, we had outstanding foreign currency forward contracts, for the exchange of U.S. dollars and Euros, with a notional amount of $9.5 million and expiration dates through September 2021.

    Counterparty default risk is considered low because the forward contracts that we entered into are over-the-counter instruments transacted with highly-rated financial institutions. We were not required to, and did not, post collateral as of October 2, 2020.

    Net foreign currency derivative losses of $0.2 million and $0.4 million were recognized in selling, general and administrative expenses during the first three quarters of 2020 and 2019, respectively. We expect $0.2 million of existing

20

foreign currency forward contract gains reported in accumulated other comprehensive loss as of October 2, 2020 to be recognized in earnings within the next 12 months.

NOTE 11

Leases

    We determine whether an arrangement contains a lease at inception. We have operating leases for office space, apartments, vehicles, and machinery and equipment. Our operating leases have lease terms of less than one year to ten years.

    We do not separate lease components from non-lease components (e.g., common area maintenance, property taxes and insurance) but account for both components in a contract as a single lease component.

    The components of lease expense are as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 2, 2020		September 27, 2019		October 2, 2020		September 27, 2019
Operating lease expense	$	1,349	$	3,827	$	5,621	$	10,890
Variable lease expense	191		196		546		594
Short-term lease expense	14,323		12,436		40,483		35,055
Total lease expense	$	15,863	$	16,459	$	46,650	$	46,539

    Supplemental balance sheet information related to our operating leases is as follows:

(In thousands)	October 2, 2020		December 31, 2019
Right-of-use assets	$	9,970	$	14,654
Current lease liabilities (recorded in other accrued liabilities)	$	3,449	$	5,743
Long-term lease liabilities (recorded in other non-current liabilities)	7,553		9,811
Total operating lease liabilities	$	11,002	$	15,554

    Additional right-of-use assets of $1.5 million were recognized as non-cash asset additions that resulted from new operating lease liabilities during the first nine months of 2020.

    The weighted average remaining lease term and discount rate for our operating leases at October 2, 2020 were 5.2 years and 6.3%, respectively.

    Maturities of lease liabilities at October 2, 2020 were as follows:

(In thousands)	Payments due
2020 (excluding the nine months ended October 2, 2020)	$	4,014
2021	2,002
2022	1,720
2023	1,483
2024	1,226
2025 and beyond	2,843
Total lease payments	13,288
Less: Imputed interest	(2,286)
Total operating lease liabilities	$	11,002

21

NOTE 12

STOCK-BASED COMPENSATION

    We maintain an equity incentive plan (the 2014 Omnibus Plan) to govern awards granted to Vectrus employees and directors, including nonqualified stock options (NQOs), restricted stock units (RSUs), total shareholder return (TSR) awards and other awards. We account for NQOs and stock-settled RSUs as equity-based compensation awards. TSR awards, described below, and cash-settled RSUs are accounted for as liability-based compensation awards and are revalued at the end of each reporting period to reflect changes in fair value.

    Stock-based compensation expense and the associated tax benefits impacting our Condensed Consolidated Statements of Income were as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 2, 2020		September 27, 2019		October 2, 2020		September 27, 2019
Compensation costs for equity-based awards	$	1,284	$	1,124	$	4,286	$	3,339
Compensation costs for liability-based awards	(196)		798		2,213		2,613
Total compensation costs, pre-tax	$	1,088	$	1,922	$	6,499	$	5,952
Future tax benefit	$	235	$	416	$	1,404	$	1,288

    As of October 2, 2020, total unrecognized compensation costs related to equity-based awards and liability-based awards were $6.7 million and $3.3 million, respectively, which are expected to be recognized ratably over a weighted average period of 1.68 years and 1.96 years, respectively.

    The following table provides a summary of the activities for NQOs and RSUs for the nine months ended October 2, 2020:

	NQOs			RSUs
(In thousands, except per share data)	Shares	Weighted Average Exercise Price Per Share		Shares	Weighted Average Grant Date Fair Value Per Share
Outstanding at January 1, 2020	77	$	23.30	301	$	30.30
Granted	—	$	—	129	$	51.98
Exercised	(3)	$	21.43	—	$	—
Vested	—	$	—	(147)	$	30.55
Issued in exchange	—	$	—	16	$	52.28
Cancelled in exchange	—	$	—	(16)	$	29.00
Forfeited or expired	—	$	—	(18)	$	40.67
Outstanding at October 2, 2020	74	$	23.37	265	$	41.41

    During the nine months ended October 2, 2020, we granted long term incentive awards to employees consisting of 108,490 RSUs with a weighted average grant date fair value per share of $52.76 and to our directors consisting of 20,311 RSUs with a weighted average grant date fair value per share of $47.76.

    On August 11, 2020, our total outstanding 15,839 CRSUs were exchanged for 15,839 RSUs. As of the exchange date, both the CRSUs and RSUs had the same vesting conditions, fair value of $52.28, and unrecognized compensation expense of $0.4 million.

    For employee RSUs, one-third of the award vests on each of the three anniversary dates following the grant date. Director RSUs are granted on the date of an annual meeting of shareholders and vest on the business day immediately prior to the next annual meeting. The fair value of each RSU grant was determined based on the closing price of Vectrus common stock on the date of grant. Stock compensation expense will be recognized ratably over the vesting period of the awards.

Total Shareholder Return Awards

    TSR awards are performance-based cash awards that are subject to a three-year performance period. Any payments earned are made in cash following completion of the performance period according to the achievement of specified performance goals. During the nine months ended October 2, 2020, we granted TSR awards with an aggregate target TSR value of $3.1 million. The fair value of TSR awards is measured quarterly and is based on the Company’s performance relative to the performance of the Aerospace and Defense Companies in the S&P 1500 Index. Depending on the Company’s performance during the three-year performance period, payments can range from 0% to 200% of the target value.

22

NOTE 13

COMMITMENTS AND CONTINGENCIES

General

    From time to time, we are involved in legal proceedings that are incidental to the operation of our business. Some of these proceedings seek remedies relating to employment matters, matters in connection with our contracts and matters arising under laws relating to the protection of the environment. Additionally, U.S. Government customers periodically advise the Company of claims and penalties concerning certain potential disallowed costs. When such findings are presented, Vectrus and the U.S. Government representatives engage in discussions to enable Vectrus to evaluate the merits of these claims as well as to assess the amounts being claimed. Where appropriate, provisions are made to reflect probable losses related to the matters raised by the U.S. Government representatives. Such assessments, along with any assessments regarding provisions for legal proceedings, are reviewed on a quarterly basis for sufficiency based on the most recent information available to us. We have estimated and accrued $11.6 million and $12.1 million as of October 2, 2020 and December 31, 2019, respectively, in "Other accrued liabilities" in the Condensed Consolidated Balance Sheets for legal proceedings and for claims with respect to our government contracts as discussed below, including open years subject to audit. Although the ultimate outcome of any legal matter or claim cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claim, we do not expect that any asserted or unasserted legal or contractual claims or proceedings, individually or in the aggregate, including the lawsuit discussed below, will have a material adverse effect on our cash flow, results of operations or financial condition.

U.S. Government Contracts, Investigations and Claims

    We have U.S. Government contracts that are funded incrementally on a year-to-year basis. Changes in government policies, priorities or funding levels through agency or program budget reductions by the U.S. Congress or executive agencies could have a material adverse effect on our financial condition or results of operations. Furthermore, our contracts with the U.S. Government may be terminated or suspended by the U.S. Government at any time, with or without cause. Such contract suspensions or terminations could result in unreimbursable expenses or charges or otherwise adversely affect our financial condition and results of operations.

    Departments and agencies of the U.S. Government have the authority to investigate various transactions and operations of the Company, and the results of such investigations may lead to administrative, civil or criminal proceedings, the ultimate outcome of which could be fines, penalties, repayments or compensatory or treble damages. U.S. Government regulations provide that certain findings against a contractor may lead to suspension or debarment from future U.S. Government contracts or the loss of export privileges for a company or an operating division or subdivision. Suspension or debarment could have a material adverse effect on the Company because of its reliance on U.S. Government contracts.

    U.S. Government agencies, including the Defense Contract Audit Agency, the Defense Contract Management Agency and others, routinely audit and review our performance on government contracts, indirect rates and pricing practices, and compliance with applicable contracting and procurement laws, regulations and standards. Accordingly, costs billed or billable to U.S. Government customers are subject to potential adjustment upon audit by such agencies. The U.S. Government agencies also review the adequacy of our compliance with government standards for our business systems, including our accounting, earned value management, estimating, materials management and accounting, purchasing, and property management systems.

    As a result of final indirect rate negotiations between the U.S. Government and our Former Parent, we may be subject to potential adjustments to costs previously allocated by our Former Parent to our business, which was formerly Exelis’ Mission Systems Business, from 2007 through 2014. We are in discussions with our Former Parent regarding the negotiated adjustments from 2007-2014 and believe that our potential cumulative liability for these years is insignificant. In June 2019, the U.S. Government provided us with the Contracting Officers Final Decision (COFD) for the years 2007-2010 related to Former Parent costs. In August 2019, we filed an appeal of the COFD with the Armed Services Board of Contract Appeals (ASBCA). Since October 2019, the ASBCA has granted Vectrus’ and the U.S. Government’s joint requests to stay proceedings in the appeal, most recently through January 11, 2021, to enable ongoing discussions regarding the matter between Vectrus and our Former Parent. In June 2020, the U.S. Government provided us with the COFD for 2013 related to Former Parent costs. In September 2020, we filed an appeal of this COFD to the ASBCA and sought a deferral of payment. In addition, we filed a motion to consolidate both appeals. The ASBCA granted our motion to consolidate. We believe we are fully indemnified under our Distribution Agreement with our Former Parent and have notified our Former Parent of our appeal of the U.S governments decision in this matter.

COVID-19 Pandemic

    On March 11, 2020, the World Health Organization designated the outbreak of COVID-19 as a global pandemic. Governments and businesses around the world have taken unprecedented actions to mitigate the spread of COVID-19, including, but not limited to, shelter-in-place orders, quarantines, significant restrictions on travel, social distancing guidelines, and restrictions on employees going to work. Uncertainty with respect to the economic impacts of the pandemic has introduced significant volatility in the financial markets. The Company has observed some disruptions on its operations due to

23

government delays related to the global pandemic. While the extent to which COVID-19 ultimately impacts the Company’s future results will depend on future developments, the pandemic and associated economic impacts could result in a material impact to the Company’s future financial condition, results of operations and cash flows.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

    The following discussion of our financial condition and results of operations should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and notes thereto included in this Quarterly Report on Form 10-Q as well as the audited Consolidated Financial Statements and notes thereto and the information under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our Annual Report on Form 10-K for the year ended December 31, 2019. This Quarterly Report provides additional information regarding the Company, our services, industry outlook and forward-looking statements that involve risks and uncertainties, including those related to the potential impact of the novel coronavirus pandemic (COVID-19) and its impact on us, our operations, or our future financial or operational results. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements. Refer to "Forward-Looking Information" for further information regarding forward-looking statements. Amounts presented in and throughout this Item 2 are rounded and, as such, any rounding differences could occur in period over period changes and percentages reported.

Overview

    Vectrus is a leading provider of global service solutions with a history in the services market that dates back more than 70 years. The company provides facility and base operations; supply chain and logistics services; information technology mission support; and engineering and digital technology services primarily to U.S. government customers around the world. Vectrus is differentiated by operational excellence, superior program performance, a history of long-term customer relationships and a strong commitment to its clients’ mission success.

    Our primary customer is the U.S. Department of Defense (DoD), with a high concentration in the U.S. Army. For the nine months ended October 2, 2020 and September 27, 2019, we had total revenue of $1,040.2 million and $1,017.4 million, respectively, substantially all of which was derived from U.S. Government customers. For the nine months ended October 2, 2020 and September 27, 2019, we generated approximately 68% and 69% of our total revenue from the U.S. Army, respectively.

Executive Summary

    Our revenue decreased $7.5 million, or 2.1%, for the three months ended October 2, 2020 compared to the three months ended September 27, 2019. The decrease in revenue is due to a temporary decrease in revenue from our existing contracts due to the COVID-19 pandemic. Revenue from our Middle East and European programs decreased by $19.2 million, and $0.4 million, respectively. This was partially offset by an increase in revenue from our U.S. programs of $12.1 million.

    Operating income for the three months ended October 2, 2020, was $14.8 million, an increase of $2.4 million, or 19.5%, compared to the three months ended September 27, 2019. This increase was due to an increase of $3.5 million from our European programs and $3.1 million from our U.S. programs, partially offset by a decrease of $4.2 million from our Middle East programs.

    During the performance of our contracts, we periodically review estimated final contract prices and costs and make revisions as required, which are recorded as changes in revenue and cost of revenue in the periods in which they are determined. Additionally, the fees under certain contracts may be increased or decreased in accordance with cost or performance incentive provisions which measure actual performance against established targets or other criteria. Such incentive fee awards or penalties are included in revenue when there is sufficient information to reasonably assess anticipated contract performance. Amounts representing contract change orders, claims, requests for equitable adjustment, or limitations in funding on contracts are recorded only if it is probable the claim will result in additional contract revenue and the amounts can be reliably estimated. Changes in estimated revenue, cost of revenue and the related effect to operating income are recognized using cumulative catch-up adjustments, which recognize in the current period the cumulative effect of the changes on current and prior periods based on a contract's percentage of completion. Cumulative catch-up adjustments due to aggregate changes in contract estimates increased operating income by less than $0.1 million and $0.7 million for the three months ended October 2, 2020 and September 27, 2019, respectively. Cumulative catch-up adjustments are driven by changes in contract terms, program performance, customer scope changes and changes to estimates in the reported period. These changes can increase or decrease operating income depending on the dynamics of each contract.

    Further details related to our financial results for the three and nine months ended October 2, 2020, compared to the three and nine months ended September 27, 2019, are contained in the "Discussion of Financial Results" section.

Recent Developments

    On April 12, 2019, the U.S. Army Contracting Command-Rock Island (ACC-RI) awarded four IDIQ, Multiple Award Task Order Contracts (MATOC), for the Logistics Civil Augmentation Program (LOGCAP) V support services in support of the

24

U.S. military worldwide. The services are to support the Geographical Combatant Commands (GCCs) and Army Service Component Commands (ASCCs) throughout the full range of military operations. Each basic IDIQ contract ordering period will be an initial five-year ordering period and options for five additional one-year ordering periods.

    Vectrus is one of four award recipients of the basic IDIQ contract and received the following task orders: INDOPACOM Setting the Theater Task Order and associated Performance Task Order; and CENTCOM Setting the Theater Task Order and associated Performance Task Order. Each task order has its own period of performance. Four of the LOGCAP V offerors filed protests of the awards with the U.S. Government Accountability Office (GAO) and, after the GAO denied two of the protests, those four offerors filed protests at the U.S. Court of Federal Claims (the Court of Federal Claims). As of March 2, 2020, the Court of Federal Claims had dismissed all offerors' protests. Vectrus received a notice to proceed with transition activities related to LOGCAP V on March 3, 2020. One of the protestors filed an appeal with the U.S. Court of Appeals for the Federal Circuit (the Federal Circuit) and all parties have filed their briefs with the court as of November 9, 2020. A second protestor had filed a notice of appeal, but subsequently withdrew its notice. No other protestors filed an appeal, and the deadline for filing such appeal has passed. We continue to monitor the status of the appeal, but the pending appeal has not impacted our transition or performance activities under LOGCAP V.

    Information regarding certain other significant contracts is discussed in "Significant Contracts" below.

COVID-19 Impact

    The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S. Government in March 2020 and has negatively affected the U.S. and global economy, disrupted global supply chains, resulted in significant travel and transport restrictions, including mandated closures and orders to “shelter-in-place,” and created significant disruption of the financial markets.  We have taken measures to protect the health and safety of our employees, to work with our customers to minimize ultimate potential disruptions, and to support our community in addressing the challenges posed by this global pandemic. The extent of the ultimate impact of the COVID-19 pandemic on our operational and financial performance, including our ability to execute our programs in the expected timeframe, will depend on future developments, including the duration and spread of the pandemic and related actions taken by the U.S. Government, state and local government officials, and international governments to prevent disease spread, all of which remain uncertain and cannot be predicted.

    During the third quarter of 2020, it is estimated that COVID-19 caused a $12.9 million reduction in our revenue and a $0.14 reduction in our diluted earnings per share. For the nine months ended October 2, 2020, the estimated impact was a $37.3 million reduction in revenue and a $0.30 reduction in earnings per share. This impact was primarily due to certain government actions to restrict access to certain bases by Vectrus personnel and delays in supplier deliveries.

    In accordance with the DoD guidance issued in March 2020 designating the Defense Industrial Base as a critical infrastructure workforce, our U.S. facilities have continued to operate in support of essential products and services required to meet our commitments to the U.S. Government and the U.S. military; however, facility closures or work slowdowns or supply chain disruptions have affected our financial results and projections. In addition, other countries are responding to the pandemic differently which have affected our international operations and the operations of our suppliers and customers. However, any closures to date have not significantly impacted Vectrus' business.

    We continue to work with our customers, employees, suppliers and communities to address the impacts of COVID-19. We continue to assess possible implications to our business, supply chain and customers and to take actions in an effort to mitigate adverse consequences in order to support our customers' mission critical business and national security.

Significant Contracts

    The following table reflects contracts that accounted for more than 10% of our total revenue for the nine months ended October 2, 2020 and September 27, 2019:

	% of Total Revenue
	Nine Months Ended
Contract Name	October 2, 2020	September 27, 2019
Kuwait Base Operations and Security Support Services (K-BOSSS)	33.3%	36.2%
Operations, Maintenance and Defense of Army Communications in Southwest Asia and Central Asia (OMDAC-SWACA)	15.2%	15.8%

    Revenue associated with a contract will fluctuate based on increases or decreases in the work being performed on the contract, award fee payment assumptions, and other contract modifications within the term of the contract resulting in changes to the total contract value. See "Backlog" below.

    The K-BOSSS contract currently is exercised through September 28, 2021. K-BOSSS supports geographically-dispersed locations within the State of Kuwait, including several camps and a range training complex. The K-BOSSS contract was re-competed as a task order under the LOGCAP V contract vehicle, which was awarded April 12, 2019 (see "Recent

25

Developments" above). The K-BOSSS contract contributed $347 million and $368 million of revenue for the nine months ended October 2, 2020 and September 27, 2019, respectively.

    The OMDAC-SWACA contract is currently exercised through February 28, 2021. The contract provides for enterprise network capabilities and services support of the U.S. Central Command. Work is based in Kuwait with additional locations throughout Southwest Asia. Vectrus has been the incumbent on OMDAC-SWACA since May 2013. The OMDAC-SWACA contract contributed $158 million and $161 million of revenue for the nine months ended October 2, 2020 and September 27, 2019, respectively.

Backlog

    Total backlog includes remaining performance obligations, consisting of funded backlog (firm orders for which funding is contractually obligated by the customer) and unfunded backlog (firm orders for which funding is not currently contractually obligated by the customer, and unexercised contract options). Total backlog excludes potential orders under IDIQ contracts and contracts awarded to us that are being protested by competitors with the GAO or in the Court of Federal Claims. The value of the backlog is based on anticipated revenue levels over the anticipated life of the contract. Actual values may be greater or less than anticipated. Total backlog is converted into revenue as work is performed. The level of order activity related to programs can be affected by the timing of government funding authorizations and their project evaluation cycles. Year-over-year comparisons could, at times, be impacted by these factors, among others.

    Our contracts are multi-year contracts and typically include an initial period of one year or less with annual one-year (or less) option periods for the remaining contract period. The number of option periods vary by contract, and there is no guarantee that an option period will be exercised. The right to exercise an option period is at the sole discretion of the U.S. Government when we are the prime contractor or of the prime contractor when we are a subcontractor. The U.S. Government may also extend the term of a program by issuing extensions or bridge contracts, typically for periods of one year or less.

    We expect to recognize a substantial portion of our funded backlog as revenue within the next 12 months. However, the U.S. Government or the prime contractor may cancel any contract at any time through a termination for convenience. Most of our contracts have terms that would permit us to recover all or a portion of our incurred costs and fees for work performed in the event of a termination for convenience.

    For the nine months ended October 2, 2020, total backlog increased by $991 million. As of October 2, 2020, total backlog (funded and unfunded) was $3.7 billion which is set forth in the following table:

	October 2,		December 31,
(In millions)	2020		2019
Funded backlog	$	1,057	$	707
Unfunded backlog	2,685		2,044
Total backlog	$	3,742	$	2,751

    Funded orders (different from funded backlog) represent orders for which funding was received during the period. We received funded orders of $1,587.6 million during the nine months ended October 2, 2020, which was an increase of $576.0 million compared to the nine months ended September 27, 2019.

Economic Opportunities, Challenges and Risks

    The U.S. Government’s investment in services and capabilities in response to changing security challenges creates a complex and fluid business environment for Vectrus and other firms in this market segment. The pace and depth of U.S. Government acquisition reform and cost savings initiatives, combined with increased industry competitiveness to win long-term positions on key programs, could add pressure to revenue levels and profit margins going forward. However, we expect the U.S. Government will continue to place a high priority on national security and will continue to invest in affordable solutions for its facilities, logistics, equipment, operational technology, and communication needs, which aligns with our services and strengths. Further, the DoD budget remains the largest in the world and management believes our addressable portion of the DoD budget offers substantial opportunity for growth. On February 10, 2020, the President submitted the FY 2021 budget request, which requests $741 billion in discretionary funding for national defense and includes $672 billion in base funding and $69 billion in overseas contingency operations funding. The Government Fiscal Year begins on October 1 and ends on September 30. The FY 2021 budget has not yet been passed by Congress and on September 30, 2020, a continuing resolution (CR) was signed into law, providing funding for federal agencies at FY 2020 spending levels through December 11, 2020. Additionally, under the CR, Section 3610 of the CARES Act, which provides authorization for federal contractors to continue to support government initiatives despite COVID-19 disruption, was also extended through December 11, 2020. If new appropriations are not passed prior to the expiration of the current CR, U.S. Government agencies may be subject to a government shutdown.

    We believe spending on operation and maintenance of defense assets, as well as civilian agency infrastructure and equipment, will continue to be a U.S. Government priority. Our focus is on sustaining facilities, equipment, and IT networks,

26

while utilizing operational technologies and converged solutions to improve efficiency and the outcomes of our clients' missions. We believe this focus aligns with our customers' intent to utilize existing equipment and infrastructure rather than executing new purchases. Many of the core functions we perform are mission-essential. The following are examples of a few of these core functions: (i) keeping communications networks operational; (ii) maintaining airfields; and (iii) providing emergency services. While customers may reduce the level of services required from us, we do not currently anticipate the complete elimination of these services.

    Currently, the ongoing COVID-19 pandemic has caused disruptions to national and global economies and a significant impact on societies, governments, markets, businesses and social norms. As an essential business and operator of critical infrastructures primarily for the DoD and the intelligence communities, we have continued to conduct our operations to support client missions while implementing measures to protect the health and safety of our employees. However, the recent COVID-19 or other outbreaks have negatively impacted our business, results of operations and financial condition in the first nine months of 2020. The continued impact to our business is currently unknown due to the uncertainty around the duration of the pandemic and its broader impact on the global economy, our clients, and employees. Potential impacts could arise from our employee’s inability to access our facilities or the facilities of our clients as well as any change in performance or cost on our contracts that might not be fully recoverable. Additionally, travel restrictions and the availability of our employee population could impact our ability to support existing and new contracts.

    The information provided above does not represent a complete list of trends and uncertainties that could impact our business in either the near or long-term and should be considered along with the risk factors identified under the caption “Risk Factors” identified in Part 1, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2019 and the matters identified under the caption “Forward-Looking Information" and Part II, Item 1A, “Risk Factors” herein.

DISCUSSION OF FINANCIAL RESULTS

Operating Income (Expense)

Three months ended October 2, 2020, compared to three months ended September 27, 2019

    Selected financial highlights are presented in the following table:

	Three Months Ended						Change
(In thousands, except for percentages)	October 2, 2020			September 27, 2019			$		%
Revenue	$	352,415		$	359,873		$	(7,458)	(2.1)	%
Cost of revenue	320,234			327,523			(7,289)		(2.2)	%
% of revenue	90.9		%	91.0		%
Selling, general, and administrative expenses	17,344			19,934			(2,590)		(13.0)	%
% of revenue	4.9		%	5.5		%
Operating income	14,837			12,416			2,421		19.5	%
Operating margin	4.2		%	3.5		%
Interest expense, net	(939)			(1,907)			(968)		(50.8)	%
Income from operations before income taxes	13,898			10,509			3,389		32.2	%
% of revenue	3.9		%	2.9		%
Income tax expense	3,507			2,668			839		31.4	%
Effective income tax rate	25.2		%	25.4		%
Net Income	$	10,391		$	7,841		$	2,550	32.5	%

Revenue

    Revenue for the three months ended October 2, 2020 was $352.4 million, a decrease of $7.5 million, or 2.1%, as compared to the three months ended September 27, 2019. The decrease in revenue was attributable to a temporary decrease in revenue from our existing contracts due to the COVID-19 pandemic. Revenue from our Middle East and European programs decreased by $19.2 million, and $0.4 million, respectively. This was partially offset by an increase in revenue from our U.S. programs of $12.1 million.

Cost of Revenue

    Cost of revenue as a percentage of revenue was 90.9% compared to 91.0% for the three months ended October 2, 2020 and September 27, 2019, respectively. The decrease in cost of revenue of $7.3 million, or 2.2%, for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily due to the volume fluctuations described for revenue.

27

Selling, General, & Administrative (SG&A) Expenses

    For the three months ended October 2, 2020, SG&A expenses of $17.3 million decreased by $2.6 million, or 13.0%, as compared to the three months ended September 27, 2019. The decrease was due primarily to a decrease in business acquisition expense of $0.3 million and a decrease in various miscellaneous expenses of $2.3 million.

Operating Income

    Operating income for the three months ended October 2, 2020 increased by $2.4 million, or 19.5%, as compared to the three months ended September 27, 2019. This increase was primarily due to increased operating income of $3.5 million and $3.1 million for our European and U.S programs, respectively, partially offset by a $4.2 million decrease in operating income from our Middle East programs.

    Operating income as a percentage of revenue was 4.2% for the three months ended October 2, 2020, compared to 3.5% for the three months ended September 27, 2019.

    Aggregate cumulative catch-up adjustments increased operating income by less than $0.1 million and $0.7 million for the three months ended October 2, 2020 and September 27, 2019, respectively. The aggregate cumulative catch-up adjustments for the three months ended October 2, 2020 related to lower margins associated with contract staffing and increased Other Direct Costs (ODCs) offset be a contract closeout adjustment. The aggregate cumulative catch-up adjustments for the three months ended September 27, 2019 related to higher margins associated with operational efficiencies related to labor and management of contract staffing and contract close-out activities.

Nine months ended October 2, 2020, compared to nine months ended September 27, 2019

    Selected financial highlights are presented in the following table:

	Nine Months Ended						Change
(In thousands, except for percentages)	October 2, 2020			September 27, 2019			$		%
Revenue	$	1,040,212		$	1,017,368		$	22,844	2.2	%
Cost of revenue	951,743			923,671			28,072		3.0	%
% of revenue	91.5		%	90.8		%
Selling, general, and administrative expenses	58,718			59,697			(979)		(1.6)	%
% of revenue	5.6		%	5.9		%
Operating income	29,751			34,000			(4,249)		(12.5)	%
Operating margin	2.9		%	3.3		%
Interest expense, net	(3,988)			(4,811)			823		(17.1)	%
Income from operations before income taxes	25,763			29,189			(3,426)		(11.7)	%
% of revenue	2.5		%	2.9		%
Income tax expense	5,593			6,657			(1,064)		(16.0)	%
Effective income tax rate	21.7		%	22.8		%
Net Income	$	20,170		$	22,532		$	(2,362)	(10.5)	%

Revenue

    Revenue for the nine months ended October 2, 2020 was $1,040.2 million, an increase of $22.8 million, or 2.2%, as compared to the nine months ended September 27, 2019. The increase in revenue was attributable to the expansion of our existing contracts. Revenue increased by $35.1 million from our U.S. programs and $3.7 million from our European programs, partially offset by a decrease of $16.0 million from our Middle East programs.

Cost of Revenue

    Cost of revenue as a percentage of revenue was 91.5% compared to 90.8% for the nine months ended October 2, 2020 and September 27, 2019, respectively. The increase in cost of revenue of $28.1 million, or 3.0%, for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily due to the volume fluctuations described for revenue.

Selling, General, & Administrative (SG&A) Expenses

    For the nine months ended October 2, 2020, SG&A expenses of $58.7 million decreased by $1.0 million, or 1.6%, as compared to the September 27, 2019 due primarily to a decrease in various miscellaneous expenses.

28

Operating Income

    Operating income for the nine months ended October 2, 2020 decreased by $4.2 million, or 12.5%, as compared to the nine months ended September 27, 2019. This decrease was primarily due to lower operating income of $4.4 million from our Middle East programs and $1.5 million from our European programs, partially offset by an increase to operating income of $1.7 million from our U.S. programs.

    Operating income as a percentage of revenue was 2.9% for the nine months ended October 2, 2020, compared to 3.3% for the nine months ended September 27, 2019.

    Aggregate cumulative catch-up adjustments decreased operating income by $3.8 million and increased operating income $1.5 million for the nine months ended October 2, 2020 and September 27, 2019, respectively. The aggregate cumulative catch-up adjustments for the nine months ended October 2, 2020 related to lower margins associated with contract staffing and increased Other Direct Costs (ODCs). The aggregate cumulative catch-up adjustments for the nine months ended September 27, 2019 related to higher margins associated with operational efficiencies related to labor and management of contract staffing and contract close-out activities.

Non-operating Income (Expense)

Interest (Expense) Income, Net

    Interest (expense) income, net for the three and nine months ended October 2, 2020 and September 27, 2019 was as follows:

	Three Months Ended				Change				Nine Months Ended				Change
(In thousands, except for percentages)	October 2, 2020		September 27, 2019		$		%		October 2, 2020		September 27, 2019		$		%
Interest income	$	27	$	61	$	(34)	(55.7)	%	$	109	$	169	$	(60)	(35.5)	%
Interest expense	(966)		(1,968)		(1,002)		(50.9)	%	(4,097)		(4,980)		(883)		(17.7)	%
Interest expense, net	$	(939)	$	(1,907)	$	(968)	(50.8)	%	$	(3,988)	$	(4,811)	$	(823)	(17.1)	%

    Interest income is directly related to interest earned on our cash. Interest expense is directly related to borrowings under our senior secured credit facilities, with the amortization of debt issuance costs, and derivative instruments used to hedge a portion of our exposure to interest rate risk. The decrease in interest expense of $0.8 million for the nine months ended October 2, 2020 compared to the nine months ended September 27, 2019 was due to greater use of our revolving credit facility in 2019 to finance short-term working capital requirements and the acquisition of Advantor.

Income Tax Expense

    We recorded income tax expense of $3.5 million and $2.7 million for the three months ended October 2, 2020 and September 27, 2019, respectively, representing effective income tax rates of 25.2% and 25.4%. For the nine months ended October 2, 2020 and September 27, 2019, respectively, we recorded income tax expense of $5.6 million and $6.7 million, respectively, representing effective income tax rates of 21.7% and 22.8%, respectively.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

    We have generated operating cash flow sufficient to fund our working capital, capital expenditures, and financing requirements. We expect to fund our ongoing working capital, capital expenditure and financing requirements and pursue additional growth through new business development and potential acquisition opportunities by using cash flows from operations, cash on hand, our credit facilities, and access to capital markets. When necessary, we will utilize our revolving credit facility to satisfy short-term working capital requirements.

    If our cash flows from operations are less than what we expect, we may need to access the long-term or short-term capital markets. Although we believe that our current financing arrangements will permit us to finance our operations on acceptable terms and conditions, our access to and the availability of financing on acceptable terms and conditions in the future will be impacted by many factors, including: (i) our credit ratings, (ii) the liquidity of the overall capital markets, and (iii) the current state of the economy. We cannot provide assurance that such financing will be available to us on acceptable terms or that such financing will be available at all.

    To date, COVID-19 has not had a significant impact on our liquidity, cash flows or capital resources. However, the continued spread of COVID-19 has also led to disruption and volatility in the global capital markets, which, depending on future developments, could impact our capital resources and liquidity in the future. To meet current and potential short-term working capital requirements and strengthen the Company's cash position in response to COVID-19 uncertainties, Vectrus drew $115 million from its revolving credit facility during the first quarter of 2020. This amount was repaid in full during the second quarter of 2020. Vectrus had net debt of $35.2 million as of December 31, 2019 and $2.3 million as of October 2, 2020.

29

    In addition, on March 27, 2020, in response to the COVID-19 pandemic, President Trump signed into law the CARES Act, which provides for the deferral of certain tax payments. The CARES Act also contains numerous other provisions which may benefit Vectrus and we continue to review ongoing government guidance on both the CARES Act and COVID-19 to assess potential impacts on our liquidity and capital resources.

    The cash presented on our Condensed Consolidated Balance Sheets consists of U.S. and international cash from wholly owned subsidiaries. Approximately $17.6 million of our total $63.7 million in cash at October 2, 2020 is held by our foreign subsidiaries and is not available to fund U.S. operations unless repatriated. We do not currently expect that we will be required to repatriate undistributed earnings of foreign subsidiaries. We expect our U.S. domestic cash resources will be sufficient to fund our U.S. operating activities and cash commitments for financing activities.

    In September 2014, we and our wholly-owned subsidiary, VSC, entered into a credit agreement with a group of lenders, including JPMorgan Chase Bank, N.A. as administrative agent. The credit agreement was subsequently amended in November 2017 by the Amendment and Restatement Agreement (the Amendment Agreement) with a group of lenders, including JPMorgan Chase Bank, N.A., as administrative agent. The Amendment Agreement provides for $200.0 million in senior secured financing, consisting of a $80.0 million five-year term loan facility (the Amended Term Loan) and a $120.0 million five-year senior secured revolving credit facility (the Amended Revolver, and together with the Amended Term Loan, the Amended Credit Facilities). There were no outstanding borrowings under the Amended Revolver at October 2, 2020. At October 2, 2020, there were two letters of credit outstanding in the aggregate amount of $2.4 million, which reduced our borrowing availability under the Amended Revolver to $117.6 million.

Dividends

    We do not currently plan to pay a regular dividend on our common stock. The declaration of any future cash dividends and the amount of any such dividends, if declared, will depend upon our financial condition, earnings, capital requirements, financial covenants and other contractual restrictions and the discretion of our Board of Directors. In deciding whether to pay future dividends on our common stock, our Board of Directors may take into account such matters as general business conditions, industry practice, our financial condition and performance, our future prospects, our cash needs and capital investment plans, income tax consequences, applicable law and such other factors as our Board of Directors may deem relevant.

Sources and Uses of Liquidity

    Cash, accounts receivable, unbilled receivables, and accounts payable are the principal components of our working capital and are generally driven by our level of revenue with other short-term fluctuations related to payment practices by our customers and the timing of our billings. Our receivables reflect amounts billed to our customers, as well as the revenue that was recognized in the preceding month, which is normally billed the month following each balance sheet date.

    The total amount of our accounts receivable can vary significantly over time and is sensitive to revenue levels and the timing of payments received from our customers. Days sales outstanding (DSO) is a metric used to monitor accounts receivable levels. The Company determines its DSO by calculating the number of days necessary to exhaust its ending accounts receivable balance based on its most recent historical revenue. Our DSO was 67 and 66 days as of October 2, 2020 and December 31, 2019, respectively.

    The following table sets forth net cash used in operating activities, investing activities and financing activities:

	Nine Months Ended
(In thousands)	October 2, 2020		September 27, 2019
Operating activities	$	37,655	$	28,448
Investing activities	(3,348)		(53,003)
Financing activities	(6,359)		699
Foreign exchange1	468		(1,239)
Net change in cash	$	28,416	$	(25,095)
1 Impact on cash balances due to changes in foreign exchange rates.

    Trends in our operating cash flows tend to follow trends in operating income, excluding non-cash charges. Net cash provided by operating activities for the nine months ended October 2, 2020 consisted of net income of $20.2 million, the favorable impact of non-cash items of $12.9 million and favorable net changes in other long-term assets and liabilities of $9.3 million partially offset by an increase in net working capital requirements of $4.7 million. Tax deferrals related to the CARES Act contributed $9.9 million to our cash flows from operating activities

    Net cash provided by operating activities during the nine months ended September 27, 2019 consisted of net income of $22.5 million, increased by non-cash items of $10.7 million and favorable net changes in other long-term assets and liabilities of $2.5 million, offset by unfavorable net changes working capital of $7.3 million.

30

    Net cash used in investing activities for the nine months ended October 2, 2020 consisted of $3.3 million of capital expenditures for the purchase of software and hardware, and vehicles and equipment related to ongoing operations. Net cash used in investing activities during the nine months ended September 27, 2019 consisted of $44.0 million for the acquisition of Advantor and $14.4 million of capital expenditures for the purchase of intangible assets, software and hardware, leasehold improvements, and vehicles and equipment related to ongoing operations. During the third quarter of 2019, $5.4 million was received from the seller of a contract acquired by the Company in the first quarter of 2019 due to the inability to have the contract novated to the Company.

    Net cash used in financing activities during the nine months ended October 2, 2020 consisted of repayments of long-term debt of $4.5 million and payments related to employee withholding taxes on share-based compensation of $1.9 million. During the nine months ended October 2, 2020, we borrowed and repaid $151.0 million on the Amended Revolver.

    Net cash provided by financing activities during the nine months ended September 27, 2019 consisted of $3.5 million in cash received from the exercise of stock options offset by repayments of long-term debt of $2.0 million and payments related to employee withholding taxes on share-based compensation in the amount of $0.8 million. During the nine months ended September 27, 2019, we borrowed and repaid a total of $226.0 million from the Amended Revolver to meet short-term working capital requirements.

Capital Resources

    At October 2, 2020, we held cash of $63.7 million, which included $17.6 million held by foreign subsidiaries, and had $117.6 million of available borrowing capacity under the Amended Revolver, which expires on November 15, 2022. We believe that our cash at October 2, 2020, as supplemented by cash flows from operations and the Amended Revolver, will be sufficient to fund our anticipated operating costs, capital expenditures, and current debt repayment obligations for at least the next 12 months.

    We have a shelf registration statement with the SEC that became effective in January 2020 under which we may issue, from time to time, up to $250 million of common stock, preferred stock, depository shares, warrants, rights and debt securities. If necessary, we may seek to obtain additional term loans or issue debt or equity under the registration statement to supplement our working capital and investing requirements or to fund acquisitions. A financing transaction may not be available on terms acceptable to us, or at all, and a financing transaction may be dilutive to our current stockholders.

Contractual Obligations

    During the nine months ended October 2, 2020, we paid $4.5 million in quarterly installment payments on the Amended Term Loan. See Note 11, "Leases" for additional contractual obligation information.

Off-Balance Sheet Arrangements

    We have obligations relating to operating leases and letters of credit outstanding. Our Amended Revolver is available for working capital, capital expenditures, and other general corporate purposes. Up to $25.0 million of the Amended Revolver is available for the issuance of letters of credit. As of October 2, 2020, there were no outstanding borrowings under the Amended Revolver and two letters of credit outstanding in the aggregate amount of $2.4 million. Both reduced our borrowing availability to $117.6 million under the Amended Revolver. These arrangements have not had, and management does not believe it is likely that they will in the future have, a material effect on our liquidity, capital resources, operations or financial condition.

CRITICAL ACCOUNTING POLICIES, ESTIMATES AND JUDGMENTS

    The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Estimates are revised as additional information becomes available. Management believes that the accounting estimates employed and the resulting balances are reasonable; however, actual results in these areas could differ from management's estimates under different assumptions or conditions.

    We believe that the assumptions and estimates associated with revenue recognition, goodwill impairment assessments, intangible assets, and income taxes have the greatest potential impact on our financial statements. Therefore, we consider these to be our critical accounting policies and estimates. There have been no material changes in our critical accounting policies and estimates from those discussed in our Annual Report on Form 10-K for the year ended December 31, 2019.

New Accounting Pronouncements

    Refer to Part I, Item 1, Note 2 "Recent Accounting Standards Update" in the notes to our unaudited Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q for information regarding accounting pronouncements and accounting standards updates.

31

FORWARD-LOOKING INFORMATION

    This Quarterly Report on Form 10-Q and certain information incorporated herein by reference contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Section 27A of the Securities Act of 1933, as amended (the Securities Act), and the Private Securities Litigation Reform Act of 1995 and, as such, may involve risks and uncertainties. All statements included or incorporated by reference in this report, other than statements that are purely historical, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “could,” “potential,” “continue” or similar terminology. These statements are based on the beliefs and assumptions of the management of the Company based on information currently available to management. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from the results contemplated by the forward-looking statements.

    We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company's historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to: the continued impact of COVID-19 on the global economy; our ability to submit proposals for and/or win all potential opportunities in our pipeline; our ability to retain and renew our existing contracts; our ability to compete with other companies in our market; security breaches and other disruptions to our information technology and operation; our mix of cost-plus, cost- reimbursable, and firm-fixed-price contracts; maintaining our reputation and relationship with the U.S. Government; protests of new awards; economic, political and social conditions in the countries in which we conduct our businesses; changes in U.S. or international government defense budgets; government regulations and compliance therewith, including changes to the DoD procurement process; changes in technology; intellectual property matters; governmental investigations, reviews, audits and cost adjustments; contingencies related to actual or alleged environmental contamination, claims and concerns; delays in completion of the U.S. Government's budget; our success in extending, deepening, and enhancing our technical capabilities; our success in expanding our geographic footprint or broadening our customer base; our ability to realize the full amounts reflected in our backlog; impairment of goodwill; misconduct of our employees, subcontractors, agents, prime contractors and business partners; our ability to control costs; our level of indebtedness; and terms of our credit agreement; interest rate risk; subcontractor performance; economic and capital markets conditions; our ability to maintain safe work sites and equipment; our ability to retain and recruit qualified personnel; our ability to maintain good relationships with our workforce; our teaming relationships with other contractors; changes in our accounting estimates; the adequacy of our insurance coverage; volatility in our stock price; changes in our tax provisions or exposure to additional income tax liabilities; risks and uncertainties relating to the Spin-off; changes in GAAP; and other factors contained below under Part II, Item 1A, “Risk Factors,” and described in Item 1A, “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2019 and described from time to time in our future reports filed with the SEC.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

    Our earnings, cash flows and financial position are exposed to market risks relating to fluctuations in interest rates and foreign currency exchange rates. All of the potential changes noted below are based on information available at October 2, 2020.

Interest Rate Risk

    Each one percentage point change associated with the variable rate Amended Term Loan would result in a $0.2 million change in our annual cash interest expenses, net of interest rate swaps in place as of October 2, 2020 to hedge a portion of this risk

     Assuming our Amended Revolver was fully drawn to a principal amount equal to $120.0 million, each one percentage point change in interest rates would result in a $1.2 million change in our annual cash interest expense.

    As of October 2, 2020, the notional value of our interest rate swap agreements totaled $49.6 million. The difference to be paid or received under the terms of the interest rate swap agreements is accrued as interest rates change and recognized as an adjustment to interest expense for the related debt in the period incurred. Changes in the variable interest rates to be paid pursuant to the terms of the interest rate swap agreements will have a corresponding effect on future cash flows. Refer to Note 10, "Derivative Instruments" in the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q for additional information regarding our interest rate swaps.

Foreign Currency Exchange Risk

    The majority of our business is conducted in U.S. dollars. However, we are required to transact in foreign currencies for some of our contracts, resulting in some assets and liabilities denominated in foreign currencies. Therefore, our earnings may experience some volatility related to movements in foreign currency exchange rates. We enter into forward foreign exchange contracts to buy or sell various foreign currencies to selectively protect against volatility in the value of non-functional currency denominated monetary assets and liabilities. Changes in the fair value of these forward contracts are recognized in earnings. As of October 2, 2020, the U.S. dollar notional value of our outstanding foreign currency forward contracts was approximately $9.5 million. The net fair value of these contracts at October 2, 2020 was $0.2 million.

32

    We perform a sensitivity analysis to determine the effects that market risk exposures may have on the fair values of our foreign currency forward contracts. To perform the sensitivity analysis, we assess the risk of loss in fair values from the effect of hypothetical changes in foreign currency exchange rates. This analysis assumes a like movement by the foreign currencies in our hedge portfolio against the U.S. dollar. As of October 2, 2020, a 5% appreciation in the value of the U.S. dollar would result in a net decrease in the fair value of our derivative portfolio of approximately $0.1 million.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

    The Company's management, with the participation of the Company's Chief Executive Officer and Acting Chief Financial Officer, evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of October 2, 2020. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of October 2, 2020, the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports the Company files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) accumulated and communicated to management to allow timely decisions regarding required disclosure. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Changes in Internal Control over Financial Reporting

    On July 8, 2019, we completed our acquisition of Advantor. We have integrated Advantor’s operations with our operations, including integration of financial reporting processes and procedures and internal controls over financial reporting. There were no material changes to our financial reporting processes and procedures and internal controls over financial reporting as a result of this integration.

    There were no changes in our internal control over financial reporting that occurred during the quarter ended October 2, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

    From time to time, we are involved in legal proceedings that are incidental to the operation of our business. Some of these proceedings seek remedies relating to employment matters, matters in connection with our contracts and matters arising under laws relating to the protection of the environment.

    Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claim, we do not expect that any asserted or unasserted legal claims or proceedings, individually or in the aggregate, will have a material adverse effect on our cash flow, results of operations or financial condition.

    Refer to Note 13 "Commitments and Contingencies" in the notes to Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q for further information.

ITEM 1A. RISK FACTORS

    We have updated certain risk factors affecting our business since those presented in our 2019 Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and those in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and July 2, 2020, respectively. Except for the risk factors set forth below, there have been no material changes in our assessment of our risk factors from those set forth in such reports.

We face various risks related to health epidemics, pandemics and similar outbreaks, particularly COVID-19, which may have material adverse effects on our business, financial position, results of operations and/or cash flows.

    The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S. Government in March 2020 and has negatively affected the U.S. and global economy, disrupted global supply chains, resulted in significant travel and transport restrictions, including mandated closures and orders to “shelter-in-place,” and created significant disruption in the global financial markets. The outbreak had an adverse impact on our operating results and our business in the first three quarters of 2020. However, the extent of the continued impact of the COVID-19 pandemic on our operational and financial performance, including our ability to execute our programs in the expected time-frame, will depend on future developments, including the duration and spread of the pandemic and related actions taken by the U.S. Government, state and local government officials, and international governments to prevent disease spread, all of which remain uncertain and cannot be predicted. Further, if significant portions of our workforce are unable to continue to work effectively because of illness, quarantine, government actions, facility closures, travel restrictions, disruptions related to increased teleworking policies, social distancing or other restrictions related to COVID-19, our operations, efficiency and effectiveness may be impacted in the future.

    It is also possible that the continued spread of COVID-19 could continue to delay or limit the ability of the U.S. Government and other customers to perform on its contractual obligations, including making timely payments to us. Essentially all of our revenue is derived from services ultimately sold to the U.S. Government, and we cannot predict the effect COVID-19 may have on our customers’ spending and mission priorities. The COVID-19 pandemic could delay the announcement of new contract awards and/or the timing of start-up or transition of our major contracts, including, but not limited to, LOGCAP V. Any prolonged interruptions in payment or transition activities on our large contracts may disrupt our cash flows, and these uncertainties could adversely affect both our operations and financial position.

    In March 2020, in response to the COVID-19 pandemic, we instituted a maximum telework policy wherever possible and eliminated all non-essential travel to protect the health and safety of our employees. We will continue to evaluate and extend these policies as necessary to continue to protect our employees. The effects on our long-term operations as a result of a significant portion of our workforce working remotely for a prolonged period are unknown. Further, prolonged telework by a large portion of our workforce presents potential cybersecurity and data security risks. In addition, as certain restrictions begin to lift worldwide, employees at many of our project sites and headquarters have begun to return to work in certain circumstances under new social distancing guidelines. We continue to monitor the World Health Organization and Center for Disease Control guidelines, as well as country, state and local guidance, and we have made significant efforts to mitigate the risks associated with returning to work. We also continue to exercise preventative measures to reduce the spread of the virus, but we cannot provide any assurances as to whether such measures will be effective or sufficient. Further, the impact of COVID-19 could worsen depending on the duration and spread of the COVID-19 outbreak or resurgences of COVID-19 infection in affected regions where we operate after they have begun to experience improvement. Any exposures to COVID-19 by our employees could affect our ability to operate effectively.

    The spread of COVID-19 has caused us to significantly modify our business practices (including limiting employee and contractor presence at our work locations), and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, contractors, customers, suppliers, and communities. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus, and our ability to perform critical functions could be adversely impacted.

34

    As the effects of COVID-19 are difficult to predict, we continue to work with our stakeholders to address this global pandemic. We continuously assess any possible implications on our business and customers to mitigate adverse consequences. Due to the many uncertainties and the rapidly changing business environment, the impacts from the COVID-19 pandemic may have a material adverse effect on our business, financial position, results of operations and/or cash flows in the future. The ongoing pandemic may also have the effect of heightening many of the other risks identified under the caption "Risk Factors" in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

    Not applicable.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

    None.

ITEM 4. MINE SAFETY DISCLOSURES

    None.

ITEM 5. OTHER INFORMATION

    None.

ITEM 6. EXHIBITS

31.1	Chief Executive Officer Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 +
31.2	Chief Financial Officer Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 +
32.1	Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This Exhibit is intended to be furnished in accordance with Regulation S-K Item 601(b)(32)(ii) and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any future filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference. +
32.2	Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This Exhibit is intended to be furnished in accordance with Regulation S-K Item 601(b)(32)(ii) and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any future filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference. +
101	The following materials from Vectrus, Inc.’s Quarterly Report on Form 10-Q for the quarter ended October 2, 2020, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Unaudited Condensed Consolidated Statements of Income, (ii) Unaudited Condensed Consolidated Statements of Comprehensive Income, (iii) Unaudited Condensed Consolidated Balance Sheets, (iv) Unaudited Condensed Consolidated Statements of Cash Flows, (v) Unaudited Condensed Consolidated Statements of Changes to Shareholders' Equity and (vi) Notes to Condensed Consolidated Financial Statements. #
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) #

+ Indicates this document is filed as an exhibit herewith.

# Submitted electronically with this report.

The Company’s Commission File Number for Reports on Form 10-K, Form 10-Q and Form 8-K is 001-36341.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VECTRUS, INC.

/s/ William B. Noon

By: William B. Noon

Corporate Vice President and Chief Accounting Officer

(Principal Accounting Officer)

Date: November 10, 2020

35

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Charles L. Prow, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Vectrus, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 10, 2020

/s/ Charles L. Prow                               

Charles L. Prow

President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Susan D. Lynch, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Vectrus, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 10, 2020

/s/ Susan D. Lynch

Susan D. Lynch

Senior Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of President and Chief Executive Officer

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report on Form 10-Q of Vectrus, Inc. (the “Company”) for the period ended October 2, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 10, 2020

/s/ Charles L. Prow                               

Charles L. Prow

President and Chief Executive Officer

EX-32.2

Exhibit 32.2

Certification of Senior Vice President and Chief Financial Officer

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report on Form 10-Q of Vectrus, Inc. (the “Company”) for the period ended October 2, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to her knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 10, 2020

/s/ Susan D. Lynch

Susan D. Lynch

Senior Vice President and Chief Financial Officer

XML

Cover - shares	9 Months Ended
	Oct. 02, 2020	Nov. 06, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 02, 2020
Document Transition Report	false
Entity File Number	001-36341
Entity Registrant Name	Vectrus, Inc.
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	38-3924636
Entity Address, Postal Zip Code	80919
Entity Address, State or Province	CO
Entity Address, City or Town	Colorado Springs,
Entity Address, Address Line One	2424 Garden of the Gods Road,
Local Phone Number	591-3600
City Area Code	(719)
Title of 12(b) Security	Common Stock, Par Value $0.01 Per Share
Trading Symbol	VEC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001601548
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		11,624,568

XML

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Income Statement [Abstract]
Revenue	$ 352,415	$ 359,873	$ 1,040,212	$ 1,017,368
Cost of revenue	320,234	327,523	951,743	923,671
Selling, general, and administrative expenses	17,344	19,934	58,718	59,697
Operating income	14,837	12,416	29,751	34,000
Interest expense, net	(939)	(1,907)	(3,988)	(4,811)
Income from operations before income taxes	13,898	10,509	25,763	29,189
Income tax expense	3,507	2,668	5,593	6,657
Net income	$ 10,391	$ 7,841	$ 20,170	$ 22,532
Earnings per share
Basic (in dollars per share)	$ 0.89	$ 0.68	$ 1.74	$ 1.97
Diluted (in dollars per share)	$ 0.88	$ 0.67	$ 1.72	$ 1.95
Weighted average common shares outstanding - basic (in shares)	11,621	11,506	11,590	11,420
Weighted average common shares outstanding - basic (in shares)	11,751	11,678	11,743	11,566

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Net income	$ 10,391	$ 7,841	$ 20,170	$ 22,532
Changes in derivative instruments:
Net (loss) gain reclassified to interest expense	0	(8)	0	43
Tax (expense) benefit	(202)	88	56	357
Net change in derivative instruments	292	(321)	(641)	(1,293)
Foreign currency translation adjustments, net of tax	2,042	(1,526)	2,578	(1,801)
Accounting Standards Update (ASU) 2018-02 reclassification of certain tax effects to Retained Earnings	0	0	0	(259)
Other comprehensive income (loss), net of tax	2,334	(1,847)	1,937	(3,353)
Total comprehensive income	12,725	5,994	22,107	19,179
Interest Rate Swap
Changes in derivative instruments:
Net change in fair value of interest rate swap	290	(194)	(1,035)	(1,570)
Foreign Currency Forward Contracts
Changes in derivative instruments:
Net change in fair value of interest rate swap	$ 204	$ (207)	$ 338	$ (123)

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019
Current assets
Cash	$ 63,734	$ 35,318
Receivables	268,143	269,144
Other current assets	24,537	16,154
Total current assets	356,414	320,616
Property, plant, and equipment, net	19,256	18,844
Goodwill	262,130	261,983
Intangible assets, net	11,902	14,926
Right-of-use assets	9,970	14,654
Other non-current assets	6,256	5,366
Total non-current assets	309,514	315,773
Total Assets	665,928	636,389
Current liabilities
Accounts payable	146,458	148,015
Compensation and other employee benefits	54,216	53,155
Short-term debt	8,000	6,500
Other accrued liabilities	38,572	37,409
Total current liabilities	247,246	245,079
Long-term debt, net	57,326	63,041
Deferred tax liability	41,734	49,407
Other non-current liabilities	35,817	19,997
Total non-current liabilities	134,877	132,445
Total liabilities	382,123	377,524
Commitments and contingencies (Note 13)
Shareholders' Equity
Preferred stock; $0.01 par value; 10,000,000 shares authorized; No shares issued and outstanding	0	0
Common stock; $0.01 par value; 100,000,000 shares authorized; 11,621,709 and 11,523,691 shares issued and outstanding as of October 2, 2020 and December 31, 2019, respectively	116	115
Additional paid in capital	81,589	78,757
Retained earnings	205,245	185,075
Accumulated other comprehensive loss	(3,145)	(5,082)
Total shareholders' equity	283,805	258,865
Total Liabilities and Shareholders' Equity	$ 665,928	$ 636,389

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 02, 2020	Dec. 31, 2019
Shareholders' Equity
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	11,621,709	11,523,691
Common stock, shares outstanding (in shares)	11,621,709	11,523,691

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Oct. 02, 2020	Apr. 03, 2020	Sep. 27, 2019	Mar. 29, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019
Operating activities
Net income	$ 10,391	$ 8,668	$ 7,841	$ 7,074	$ 20,170	$ 22,532
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense					3,001	2,395
Amortization of intangible assets	1,000		800		3,031	2,103
Loss on disposal of property, plant, and equipment					63	2
Stock-based compensation					6,499	5,952
Amortization of debt issuance costs					286	301
Changes in assets and liabilities:
Receivables					3,584	(7,540)
Other assets					(8,826)	(5,820)
Accounts payable					(1,988)	(14,458)
Deferred taxes					(7,575)	(4,670)
Compensation and other employee benefits					813	17,863
Other liabilities					18,597	9,788
Net cash provided by operating activities					37,655	28,448
Investing activities
Purchases of capital assets and intangibles					(3,348)	(14,440)
Proceeds from the disposition of assets					0	5,400
Acquisition of business, net of cash acquired					0	(43,963)
Net cash (used in) investing activities					(3,348)	(53,003)
Financing activities
Repayments of long-term debt					(4,500)	(2,000)
Proceeds from revolver					151,000	226,000
Repayments of revolver					(151,000)	(226,000)
Proceeds from exercise of stock options					59	3,467
Payments of employee withholding taxes on share-based compensation					(1,918)	(768)
Net cash (used in) provided by financing activities					(6,359)	699
Exchange rate effect on cash					468	(1,239)
Net change in cash					28,416	(25,095)
Cash-beginning of year		$ 35,318		$ 66,145	35,318	66,145	$ 66,145
Cash-end of period	$ 63,734		$ 41,050		63,734	41,050	$ 35,318
Supplemental disclosure of cash flow information:
Interest paid					3,030	4,363
Income taxes paid					12,570	5,076
Non-cash investing activities:
Purchase of capital assets on account					$ 373	$ 394

XML

Condensed Consolidated Statements of Changes to Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock Issued	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Dec. 31, 2018			11,267
Balance at Dec. 31, 2018	$ 220,324	$ 0	$ 113	$ 71,729	$ 151,640	$ 259	$ (3,158)	$ (259)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,074				7,074
Foreign currency translation adjustments	(823)						(823)
Unrealized gain (loss) on cash flow hedge	(360)						(360)
Employee stock awards and stock options (in shares)			85
Employee stock awards and stock options	602		$ 1	601
Taxes withheld on restricted stock unit compensation awards	(683)			(683)
Stock-based compensation	1,117			1,117
Balance (in shares) at Mar. 29, 2019			11,352
Balance at Mar. 29, 2019	227,251		$ 114	72,764	158,973		(4,600)
Balance (in shares) at Dec. 31, 2018			11,267
Balance at Dec. 31, 2018	220,324	0	$ 113	71,729	151,640	259	(3,158)	(259)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	22,532
Foreign currency translation adjustments	(1,801)
Unrealized gain (loss) on cash flow hedge	(1,293)
Balance (in shares) at Sep. 27, 2019			11,506
Balance at Sep. 27, 2019	245,801		$ 115	77,766	174,431		(6,511)
Balance (in shares) at Dec. 31, 2018			11,267
Balance at Dec. 31, 2018	220,324	$ 0	$ 113	71,729	151,640	$ 259	(3,158)	$ (259)
Balance (in shares) at Dec. 31, 2019			11,524
Balance at Dec. 31, 2019	258,865		$ 115	78,757	185,075		(5,082)
Balance (in shares) at Mar. 29, 2019			11,352
Balance at Mar. 29, 2019	227,251		$ 114	72,764	158,973		(4,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,617				7,617
Foreign currency translation adjustments	547						547
Unrealized gain (loss) on cash flow hedge	(611)						(611)
Employee stock awards and stock options (in shares)			154
Employee stock awards and stock options	2,865		$ 1	2,864
Taxes withheld on restricted stock unit compensation awards	(85)			(85)
Stock-based compensation	1,099			1,099
Balance (in shares) at Jun. 28, 2019			11,506
Balance at Jun. 28, 2019	238,683		$ 115	76,642	166,590		(4,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,841				7,841
Foreign currency translation adjustments	(1,526)						(1,526)
Unrealized gain (loss) on cash flow hedge	(321)						(321)
Stock-based compensation	1,124			1,124
Balance (in shares) at Sep. 27, 2019			11,506
Balance at Sep. 27, 2019	245,801		$ 115	77,766	174,431		(6,511)
Balance (in shares) at Dec. 31, 2019			11,524
Balance at Dec. 31, 2019	258,865		$ 115	78,757	185,075		(5,082)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,668				8,668
Foreign currency translation adjustments	(1,934)						(1,934)
Unrealized gain (loss) on cash flow hedge	(1,290)						(1,290)
Employee stock awards and stock options (in shares)			64
Employee stock awards and stock options	1		$ 1	0
Taxes withheld on restricted stock unit compensation awards	(1,787)			(1,787)
Stock-based compensation	1,720			1,720
Balance (in shares) at Apr. 03, 2020			11,588
Balance at Apr. 03, 2020	264,243		$ 116	78,690	193,743		(8,306)
Balance (in shares) at Dec. 31, 2019			11,524
Balance at Dec. 31, 2019	258,865		$ 115	78,757	185,075		(5,082)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	20,170
Foreign currency translation adjustments	2,578
Unrealized gain (loss) on cash flow hedge	(641)
Balance (in shares) at Oct. 02, 2020			11,622
Balance at Oct. 02, 2020	$ 283,805		$ 116	81,589	205,245		(3,145)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201815Member
Balance (in shares) at Apr. 03, 2020			11,588
Balance at Apr. 03, 2020	$ 264,243		$ 116	78,690	193,743		(8,306)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,111				1,111
Foreign currency translation adjustments	2,470						2,470
Unrealized gain (loss) on cash flow hedge	357						357
Employee stock awards and stock options (in shares)			32
Employee stock awards and stock options	58		$ 0	58
Taxes withheld on restricted stock unit compensation awards	(86)			(86)
Stock-based compensation	1,282			1,282
Balance (in shares) at Jul. 03, 2020			11,620
Balance at Jul. 03, 2020	269,435		$ 116	79,944	194,854		(5,479)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	10,391				10,391
Foreign currency translation adjustments	2,042						2,042
Unrealized gain (loss) on cash flow hedge	292						292
Employee stock awards and stock options (in shares)			2
Employee stock awards and stock options	0		$ 0	0
Conversion of liability-based stock compensation awards to equity-based stock compensation awards	405			405
Taxes withheld on restricted stock unit compensation awards	(44)			(44)
Stock-based compensation	1,284			1,284
Balance (in shares) at Oct. 02, 2020			11,622
Balance at Oct. 02, 2020	$ 283,805		$ 116	$ 81,589	$ 205,245		$ (3,145)

XML

Description of Business and Summary of Significant Accounting Policies

9 Months Ended

Oct. 02, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business and Summary of Significant Accounting Policies

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of Business and Basis of Presentation

Our Business

    Vectrus, Inc. is a leading provider of services to the United States Government (U.S. Government) worldwide. The Company operates as one segment and provides the following services and offerings: facility and base operations; supply chain and logistics services; information technology mission support; and engineering and digital technology services.

    Vectrus was incorporated in the State of Indiana on February 4, 2014. On September 27, 2014, Exelis Inc. (Exelis) completed a spin-off (the Spin-off) of Vectrus, and Vectrus became an independent, publicly traded company. Unless the context otherwise requires, references in these notes to "Vectrus", "we," "us," "our," "the Company" and "our Company" refer to Vectrus, Inc. References in these notes to Exelis or "Former Parent" refer to Exelis Inc. and its consolidated subsidiaries (other than Vectrus) or successor entities.

Basis of Presentation

    Our quarterly financial periods end on the Friday closest to the last day of the calendar quarter (October 2, 2020 for the third quarter of 2020 and September 27, 2019 for the third quarter of 2019), except for the last quarter of the fiscal year, which ends on December 31. For ease of presentation, the quarterly financial statements included herein are described as three months ended.

    The unaudited interim Condensed Consolidated Financial Statements of Vectrus have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been omitted. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019.

    It is management’s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the Company’s financial position and operating results. Revenue and net income for any interim period are not necessarily indicative of future or annual results.

Immaterial Restatement of Prior Period Balances

    Subsequent to the issuance of our Annual Report on Form 10-K for the year ended December 31, 2019, we identified an error in our historical financial statements related to estimated contract costs for the year ended December 31, 2019 as well as an error in our historical financial statements related to overbilling for a separate contract dating back to 2013, prior to the Spin-off. In the first instance, management determined that additional subcontractor costs should have been included as part of estimated contract costs, resulting in a misstatement in other accrued liabilities and cost of revenue as well as revenue and accounts receivable to a lesser extent. In the second instance, management identified that certain contract costs were incorrectly included in customer billings for one contract, resulting in a misstatement in revenue and other accrued liabilities.

    The cumulative impact of the errors was a $2.5 million decrease in retained earnings as of December 31, 2019. The impact of the errors on net income for the year ended December 31, 2019 is $1.5 million. The impact on diluted earnings per share is a decrease of $0.13 for the year ended December 31, 2019. The impact to diluted earnings per share in the first, second, third, and fourth quarters of 2019 is a decrease of $0.00, $0.00, $0.13, and $0.00, respectively. The impact on diluted earnings per share is a decrease of $0.02 and $0.01 for the years ended December 31, 2018 and 2017, respectively. 

    Accordingly, the Company is restating the relevant financial statements and related footnotes for all applicable periods for these errors and related tax effect and will correct the respective financial statements as they appear in future filings. Management has evaluated the materiality of these misstatements and concluded they were not material to prior periods, individually or in aggregate.

    The effects of the corrections to each of the individual affected line items in our Condensed Consolidated Statements of Income were as follows:

	Three Months Ended September 27, 2019						Nine Months Ended September 27, 2019
(In thousands, except per share data)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Revenue	$	359,854	$	19	$	359,873	$	1,017,371	$	(3)	$	1,017,368
Cost of revenue	325,537		1,986		327,523		921,685		1,986		923,671
Operating income	14,383		(1,967)		12,416		35,989		(1,989)		34,000
Income from operations before income taxes	12,476		(1,967)		10,509		31,178		(1,989)		29,189
Income tax expense	3,094		(426)		2,668		7,088		(431)		6,657
Net income	$	9,382	$	(1,541)	$	7,841	$	24,090	$	(1,558)	$	22,532
Earnings per share
Basic	$	0.82	$	(0.14)	$	0.68	$	2.11	$	(0.14)	$	1.97
Diluted	$	0.80	$	(0.13)	$	0.67	$	2.08	$	(0.13)	$	1.95

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Comprehensive Income were as follows:

	Three Months Ended September 27, 2019						Nine Months Ended September 27, 2019
(In thousands)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Net income	$	9,382	$	(1,541)	$	7,841	$	24,090	$	(1,558)	$	22,532
Total comprehensive income	$	7,535	$	(1,541)	$	5,994	$	20,737	$	(1,558)	$	19,179

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Balance Sheet were as follows:

	December 31, 2019
(In thousands)	As Previously Reported		Correction		As Corrected
Receivables	$	269,239	$	(95)	$	269,144
Total current assets	320,711		(95)		320,616
Total Assets	636,484		(95)		636,389
Other accrued liabilities	34,587		2,822		37,409
Total current liabilities	242,257		2,822		245,079
Deferred tax liability	49,808		(401)		49,407
Total non-current liabilities	132,846		(401)		132,445
Total Liabilities	375,103		2,421		377,524
Retained earnings	187,591		(2,516)		185,075
Total shareholders' equity	261,381		(2,516)		258,865
Total Liabilities and Shareholders' Equity	$	636,484	$	(95)	$	636,389

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Cash Flows were as follows:

	Nine Months Ended September 27, 2019
(In thousands)	As Previously Reported		Correction		As Corrected
Net income	$	24,090	$	(1,558)	$	22,532
Changes in receivables	(7,521)		(19)		(7,540)
Changes in deferred taxes	(4,240)		(430)		(4,670)
Changes in other liabilities	7,781		2,007		9,788
Net cash provided in operating activities	$	28,448	$	—	$	28,448

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Changes in Shareholders' Equity were as follows:

	Retained Earnings						Total Shareholders' Equity
(In thousands)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Balance at December 31, 2018	$	152,616	$	(976)	$	151,640	$	221,300	$	(976)	$	220,324
Net income	7,091		(17)		7,074		7,091		(17)		7,074
Balance at March 29, 2019	159,966		(993)		158,973		228,244		(993)		227,251
Net income	7,617		—		7,617		7,617		—		7,617
Balance at June 28, 2019	167,583		(993)		166,590		239,676		(993)		238,683
Net income	9,382		(1,541)		7,841		9,382		(1,541)		7,841
Balance at September 27, 2019	$	176,965	$	(2,534)	$	174,431	$	248,335	$	(2,534)	$	245,801

XML

Recent Accounting Standards Update

9 Months Ended

Oct. 02, 2020

Accounting Standards Update and Change in Accounting Principle [Abstract]

Recent Accounting Standards Update

RECENT ACCOUNTING STANDARDS UPDATE

Accounting Standards Issued but Not Yet Effective

    In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes (ASU 2019-12). The objectives of ASU 2019-12 are (i) to simplify the accounting for income taxes by removing certain exceptions, (ii) to update certain requirements to simplify the accounting for income taxes, and (iii) to make minor codification improvements for income taxes. The guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the adoption of this standard to have a material impact on the Company’s financial statements.

Accounting Standards That Were Adopted

    In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) (ASU 2018-15). The objective of ASU 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with those incurred to develop or obtain internal-use software. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The amendments can be applied either retrospectively or prospectively. We adopted ASU 2018-15 on January 1, 2020 using the retrospective method. As a result of the adoption, $0.3 million was reclassified from 2019 year-end property, plant and equipment, net, to other non-current assets on our Condensed Consolidated Balance Sheet. In addition, $0.3 million of cash outflows from investing activities incurred during the third and fourth quarters of 2019 was reclassified to cash outflows from operating activities.

    In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (ASU 2017-04). The objective of ASU 2017-04 is to simplify the subsequent measurement of goodwill by entities performing their annual goodwill impairment tests by comparing the fair value of a reporting unit, including income tax effects from any tax-deductible goodwill, with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds fair value. ASU 2017-04 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2017-04 should be applied on a prospective basis. We adopted ASU 2017-04 on January 1, 2020.  The adoption of the standard did not have a material impact on our financial statements.    

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with more useful information about the expected credit losses

on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. We adopted the standard on January 1, 2020. The adoption of the standard did not have a material impact on our financial statements.

XML

Revenue

9 Months Ended

Oct. 02, 2020

Revenue from Contract with Customer [Abstract]

Revenue

REVENUE

Performance Obligations

    A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account for revenue in ASC Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. To determine the proper revenue recognition method, consideration is given as to whether a single contract should be accounted for as more than one performance obligation. For most of our contracts, the customer contracts with us to perform an integrated set of tasks and deliverables as a single service solution, whereby each service is not separately identifiable from other promises in the contract and therefore is not distinct. As a result, when this integrated set of tasks exists, the contract is accounted for as one performance obligation. The vast majority of our contracts have a single performance obligation. Unexercised contract options and indefinite delivery and indefinite quantity (IDIQ) contracts are considered to be separate performance obligations when the option or IDIQ task order is exercised or awarded.

    Contract modifications are routine in the performance of our contracts. Contracts are often modified to account for changes in contract specifications or requirements. In most instances, contract modifications are for goods or services that are not distinct, and therefore, are accounted for as part of the existing contract. Modifications to exercise option years create new enforceable rights and obligations and therefore are treated as separate performance obligations.

    The Company's performance obligations are typically satisfied over time as services are provided throughout the contract term. We recognize revenue over time using the input method (e.g., costs incurred to date relative to total estimated costs at completion) to measure progress. Our over time recognition is reinforced by the fact that our customers simultaneously receive and consume the benefits of our services as they are performed. This continuous transfer of control requires that we track progress towards completion of performance obligations in order to measure and recognize revenue. Determining progress on performance obligations requires us to make judgments that affect the timing of revenue recognition. Remaining performance obligations represent firm orders by the customer and excludes potential orders under IDIQ contracts, unexercised contract options, and contracts awarded to us that are being protested by competitors with the U.S. Government Accountability Office (GAO) or in the U.S. Court of Federal Claims. The level of order activity related to contracts can be affected by the timing of government funding authorizations and their project evaluation cycles. Year-over-year comparisons could, at times, be impacted by these factors, among others.

    The Company's contracts are multi-year contracts and typically include an initial period of one year or less with annual one-year (or less) option periods. The number of option periods varies by contract, and there is no guarantee that an option period will be exercised. The right to exercise an option period is at the sole discretion of the U.S. Government when we are the prime contractor or of the prime contractor when we are a subcontractor. We expect to recognize a substantial portion of our performance obligations as revenue within the next 12 months. However, the U.S. Government or the prime contractor may cancel any contract at any time through a termination for convenience or for cause. Substantially all of our contracts have terms that would permit us to recover all or a portion of our incurred costs and fees for work performed in the event of a termination for convenience.

    Remaining performance obligations increased by $306.4 million as of October 2, 2020 as compared to December 31, 2019. We expect to recognize approximately 30% of the remaining performance obligations as of October 2, 2020 as revenue in 2020, and the remaining 70% during 2021. Remaining performance obligations as of October 2, 2020 and December 31, 2019 are presented in the following table:

	October 2,		December 31,
(In thousands)	2020		2019
Performance Obligations	$	1,155,742	$	849,389

Contract Estimates

    Accounting for contracts involves the use of various techniques to estimate total contract revenue and costs. We estimate the profit on our contracts as the difference between the total estimated revenue and expected costs to complete a contract and recognize that profit over the life of the contract.

    Contract estimates are based on various assumptions to project the outcome of future events. These assumptions include labor productivity and availability; the complexity of the services being performed; the cost and availability of materials; the performance of subcontractors; and the availability and timing of funding from the customer.

    The impact of adjustments in contract estimates on our operating income can be reflected in either revenue or cost of revenue. Cumulative catch-up adjustments for the three and nine months ended October 2, 2020 were favorable to operating income by less than $0.1 million and unfavorable to operating income by $3.8 million, respectively. For the three and nine months ended September 27, 2019, the net favorable adjustments to operating income were $0.7 million and $1.5 million, respectively.

    For the three and nine months ended October 2, 2020 the cumulative catch-up adjustments to operating income decreased revenue by $1.1 million and $0.5 million, respectively. For the three and nine months ended September 27, 2019, the cumulative catch-up adjustments to operating income increased revenue by $4.0 million and $4.2 million, respectively.

Revenue by Category

    Generally, the sales price elements for our contracts are cost-plus, cost-reimbursable or firm-fixed-price. We commonly have elements of cost-plus, cost-reimbursable and firm-fixed-price contracts on a single contract. On a cost-plus type contract, we are paid our allowable incurred costs plus a profit, which can be fixed or variable depending on the contract’s fee arrangement, up to funding levels predetermined by our customers. On cost-plus type contracts, we do not bear the risks of unexpected cost overruns, provided that we do not incur costs that exceed the predetermined funded amounts. Cost-plus type contracts with award and incentive fee provisions are our primary variable contract fee arrangement. Award fees provide for a fee based on actual performance relative to contractually specified performance criteria. Incentive fees provide for a fee based on the relationship between total allowable and target cost. On most of our contracts, a cost-reimbursable element captures consumable materials required for the contract. Typically, these costs do not bear fees.

    On a firm-fixed-price type contract, we agree to perform the contractual statement of work for a predetermined contract price. A firm-fixed-price type contract typically offers higher profit margin potential than a cost-plus type contract, which is commensurate with the greater levels of risk we assume on a firm-fixed-price type contract. Although a firm-fixed-price type contract generally permits us to retain profits if the total actual contract costs are less than the estimated contract costs, we bear the risk that increased or unexpected costs may reduce our profit or cause us to sustain losses on the contract. Although the overall scope of work required under the contract may not change, profit may be adjusted as experience is gained and as efficiencies are realized or costs are incurred.

    The following tables present our revenue disaggregated by several categories. Revenue by contract type for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Cost-plus and cost-reimbursable ¹	$	249,484	$	272,810	(8.6)	%	$	748,543	$	781,024	(4.2)	%
Firm-fixed-price	102,931		87,063		18.2	%	291,669		236,344		23.4	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368
¹ Includes time and material contracts

    Revenue by geographic region in which the contract is performed for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Middle East	$	224,934	$	244,142	(7.9)	%	$	679,633	$	695,626	(2.3)	%
United States	89,400		77,228		15.8	%	254,640		219,512		16.0	%
Europe	38,081		38,503		(1.1)	%	105,939		102,230		3.6	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

    Revenue by contract relationship for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Prime contractor	$	332,564	$	334,402	(0.5)	%	$	980,301	$	954,191	2.7	%
Subcontractor	19,851		25,471		(22.1)	%	59,911		63,177		(5.2)	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

    Revenue by customer for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2.		September 27,		%		October 2.		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Army	$	236,267	$	245,817	(3.9)	%	$	711,173	$	698,377	1.8	%
Air Force	79,425		86,576		(8.3)	%	231,088		227,100		1.8	%
Navy	18,785		13,344		40.8	%	48,564		45,227		7.4	%
Other	17,938		14,136		26.9	%	49,387		46,664		5.8	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

Contract Balances

    The timing of revenue recognition, billings and cash collections results in billed and unbilled accounts receivable (contract assets) and customer advances and deposits (contract liabilities) on the Condensed Consolidated Balance Sheets. Amounts are billed as work progresses in accordance with agreed-upon contractual terms at periodic intervals (e.g., biweekly or monthly). Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. However, we may receive advances or deposits from our customers, before revenue is recognized, resulting in contract liabilities. These advance billings and payments are not considered significant financing components because they are frequently intended to ensure that both parties are in conformance with the primary contract terms. These assets and liabilities are reported on the Condensed Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period.

    As of October 2, 2020 and December 31, 2019, we had contract assets of $199.3 million and $186.4 million, respectively. Refer to Note 8, "Receivables" for additional information regarding the composition of our receivable balances. As of both October 2, 2020 and December 31, 2019, our contract liabilities were insignificant.

XML

Income Taxes

9 Months Ended

Oct. 02, 2020

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

Effective Tax Rate

    Income tax expense during interim periods is based on an estimated annual effective income tax rate, plus any significant unusual or infrequently occurring items recorded in interim periods. The computation of the estimated effective income tax rate at each interim period requires certain estimates and judgment including, but not limited to, forecasted operating income for the year, projections of the income earned and taxed in various jurisdictions, newly enacted tax rate and legislative changes, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year.

    For the quarters ended October 2, 2020 and September 27, 2019, we recorded an income tax provision of $3.5 million and $2.7 million, respectively, representing effective income tax rates of 25.2% and 25.4%. For the nine months ended October 2, 2020 and September 27, 2019, we recorded income tax provisions of $5.6 million and $6.7 million, representing effective income tax rates of 21.7% and 22.8%, respectively. The effective income tax rates vary from the federal statutory rate of 21.0% due to state and foreign taxes, required tax income exclusions, nondeductible expenses and available deductions not reflected in book income.

Uncertain Tax Provisions

    As of October 2, 2020, and December 31, 2019, unrecognized tax benefits from uncertain tax positions were $12.5 million and $7.9 million, respectively. The increase in the uncertain tax positions was principally the result of the additional Foreign Derived Intangible Income (FDII) deduction.

XML

Acquisitions

9 Months Ended

Oct. 02, 2020

Business Combinations [Abstract]

Acquisitions

ACQUISITIONS

Advantor

    On July 8, 2019, we acquired Advantor from Infrasafe Holding, Inc. and Infrasafe, LLC (collectively, Infrasafe). Advantor is a leading provider of integrated electronic security systems to the U.S. Government. In accordance with ASC Topic 805, Business Combinations, we accounted for this transaction using the acquisition method. We conducted valuations of certain acquired assets and liabilities for inclusion in our Condensed Consolidated Balance Sheets as of the date of acquisition. Assets that normally would not be recorded in ordinary operations (i.e. intangibles related to contractual relationships) were recorded at their estimated fair values. The excess purchase price over the estimated fair value of the net assets acquired was recorded as goodwill.

    The total net consideration paid for the acquisition was $45.1 million, consisting of the purchase price of $44.0 million, net of cash acquired, and $1.1 million for working capital in excess of the working capital requirement agreed upon in the stock purchase agreement. The acquisition was funded by utilizing cash on hand and available capacity from our Amended Revolver (as defined in Note 9, “Debt”).

    A breakdown of the purchase price allocation, net of cash acquired, is as follows:

(In thousands)	Allocation of Purchase Price
Receivables	$	11,388
Other current assets	2,719
Property, plant and equipment	155
Goodwill	28,511
Intangible assets	8,300
Other non-current assets	1,868
Accounts payable	(4,223)
Other current liabilities	(1,519)
Accrued compensation	(907)
Other non-current liabilities	(1,218)
Purchase price, net of cash acquired	$	45,074

    We completed purchase accounting for the acquisition as of July 3, 2020 with no material adjustments. The Company recognized two intangible assets related to customer contracts (backlog) and the Advantor trade name arising from the acquisition. The fair value of the customer contracts was $7.2 million, and the fair value of the Advantor trade name was $1.1 million with amortization periods of 5.0 years and 4.5 years, respectively. As of October 2, 2020, the remaining weighted-average amortization period for these intangible assets was 3.7 years. The Company recorded amortization expense of $1.3

million during the first nine months of 2020. The amortization expense is included in cost of revenue in our Condensed Consolidated Statements of Income.

    Additionally, the Company recognized goodwill of $28.5 million arising from the acquisition, which relates primarily to acquired product and services strengthening our advance into a higher value, technology-enabled and differentiated platform, as well as extending our facilities and logistics services to include the electronic protection and security of facilities. Goodwill also includes other intangibles that do not qualify for separate recognition. The goodwill recognized for the Advantor acquisition is fully deductible for income tax purposes.

    Advantor's operating results have been included in our reported results since the date of acquisition.

XML

Goodwill and Intangible Assets

9 Months Ended

Oct. 02, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

GOODWILL AND INTANGIBLE ASSETS

    As of October 2, 2020 and December 31, 2019 the carrying amount of goodwill was $262.1 million and $262.0 million, respectively. The $0.1 million increase during the first nine months of 2020 is due to a final adjustment to the Advantor purchase price allocation.

    The Company tests goodwill for impairment as of the beginning of the fourth quarter each year, or more frequently should circumstances change or events occur that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Due to the COVID-19 pandemic and the negative effect on the U.S. and global economy, the Company completed a qualitative assessment to evaluate whether or not it is more likely than not that the fair value of goodwill is less than its carrying amount. Based on our assessment of the totality of events and circumstances as of October 2, 2020, including the estimated impact of the COVID-19 pandemic on our business forecast and the Company's market capitalization, we determined that it is not more likely than not that the fair value of our reporting unit is below its carrying amount.

    Identifiable intangible assets consist of the following:

	October 2, 2020						December 31, 2019
(In thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Contract backlogs and recompetes	$	11,600	$	(6,053)	$	5,547	$	11,600	$	(4,300)	$	7,300
Customer contracts	7,200		(1,773)		5,427		7,200		(692)		6,508
Trade names and other	1,243		(315)		928		1,236		(118)		1,118
Balance	$	20,043	$	(8,141)	$	11,902	$	20,036	$	(5,110)	$	14,926

     Identifiable intangible asset amortization expense was $1.0 million and $3.0 million for the three and nine months ended October 2, 2020, respectively. Intangible amortization expense for the three and nine months ended September 27, 2019 was $0.8 million and $2.1 million, respectively. As of October 2, 2020, the remaining average intangible asset amortization period was 3.6 years.

    The estimated amortization expense for the next five years is as follows (in thousands):

Period	Amortization
2020 (excluding the nine months ended October 2, 2020)	$	998
2021	$	4,029
2022	$	2,501
2023	$	2,404
2024	$	1,297
After 2024	$	673

XML

Earnings Per Share

9 Months Ended

Oct. 02, 2020

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

    Basic earnings per share (EPS) is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS reflects potential dilution that could occur if securities to issue common stock were exercised or converted into common stock. Diluted EPS includes the dilutive effect of stock-based compensation outstanding after application of the treasury stock method.

	Three Months Ended				Nine Months Ended
	October 2,		September 27,		October 2,		September 27,
(In thousands, except per share data)	2020		2019		2020		2019
Net income	$	10,391	$	7,841	$	20,170	$	22,532
Weighted average common shares outstanding	11,621		11,506		11,590		11,420
Add: Dilutive impact of stock options	34		37		38		45
Add: Dilutive impact of restricted stock units	96		135		115		101
Diluted weighted average common shares outstanding	11,751		11,678		11,743		11,566
Earnings per share
Basic	$	0.89	$	0.68	$	1.74	$	1.97
Diluted	$	0.88	$	0.67	$	1.72	$	1.95

    The following table provides a summary of securities that could potentially dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented:

	Three Months Ended		Nine Months Ended
	October 2,	September 27,	October 2,	September 27,
(In thousands)	2020	2019	2020	2019
Anti-dilutive stock options	—	—	—	1
Anti-dilutive restricted stock units	3	—	2	3
Total	3	—	2	4

XML

Receivables

9 Months Ended

Oct. 02, 2020

Receivables [Abstract]

Receivables

RECEIVABLES

    Receivables were comprised of the following:

(In thousands)	October 2, 2020		December 31, 2019
Billed receivables	$	59,445	$	71,068
Unbilled receivables (contract assets)	199,301		186,365
Other	9,397		11,711
Total receivables	$	268,143	$	269,144

    As of October 2, 2020 and December 31, 2019, substantially all billed receivables are due from the U.S. Government, either directly as prime contractor to the U.S. Government or as subcontractor to another prime contractor to the U.S. Government. Because our billed receivables are with the U.S. Government, we do not believe they represent a material credit risk exposure.

    Unbilled receivables are contract assets that represent revenue recognized on long-term contracts in excess of amounts billed as of the balance sheet date. We estimate that approximately $6.1 million of our unbilled receivables as of October 2, 2020 may not be collected within the next 12 months. These amounts relate to the timing of the U.S. Government review of indirect rates and contract line item realignments with our customers. Changes in the balance of receivables are primarily due to the timing differences between our performance and customers' payments.

XML

Debt

9 Months Ended

Oct. 02, 2020

Debt Disclosure [Abstract]

Debt

DEBT

Senior Secured Credit Facilities

    Term Loan and Revolver. In September 2014, we and our wholly-owned subsidiary, VSC, entered into a credit agreement with a group of lenders, including JPMorgan Chase Bank, N.A. as administrative agent. The credit agreement was subsequently amended in November 2017 by the Amendment and Restatement Agreement (the Amendment Agreement) with a group of lenders, including JPMorgan Chase Bank, N.A., as administrative agent. The Amendment Agreement provides for $200.0 million in senior secured financing, consisting of a $80.0 million five-year term loan facility (the Amended Term Loan) and a $120.0 million five-year senior secured revolving credit facility (the Amended Revolver, and together with the Amended Term Loan, the Amended Credit Facilities).

    Additionally, the Amendment Agreement includes an accordion feature that allows the Company to draw up to an additional $100.0 million, subject to the lender's consent. The Amendment Agreement also permits the Company to borrow up to $75.0 million in unsecured debt as long as the aggregated sum of both the unsecured debt and the accordion does not exceed $100.0 million.

    The Amended Revolver is available for working capital, capital expenditures, and other general corporate purposes. Up to $25.0 million of the Amended Revolver is available for the issuance of letters of credit. As of October 2, 2020, there were two letters of credit outstanding in the aggregate amount of $2.4 million, and no outstanding borrowings under the Amended Revolver resulting in borrowing capacity of $117.6 million under the Amended Revolver. The Amended Revolver will mature and the commitments thereunder will terminate on November 15, 2022.

    The aggregate scheduled maturities of the Amended Term Loan, are as follows:

(In thousands)	Payments due
2020 (excluding the nine months ended October 2, 2020)	$	2,000
2021	8,600
2022	55,400
Total	$	66,000

    Voluntary Prepayments. We may voluntarily prepay the Amended Term Loan in whole or in part at any time without premium or penalty, subject to the payment of customary breakage costs under certain conditions. Amounts borrowed under the Amended Term Loan that are repaid or prepaid may not be re-borrowed.

    Covenants. The Amended Credit Facilities contain customary covenants, including covenants that, under certain circumstances and subject to certain qualifications and exceptions: limit or restrict our ability to incur additional indebtedness; merge, dissolve, liquidate or consolidate; make acquisitions, investments, advances or loans; dispose of or transfer assets; pay dividends; redeem or repurchase certain debt; and enter into certain restrictive agreements.

    In addition, we are required to comply with (a) a maximum ratio of total consolidated indebtedness to consolidated earnings before interest, tax, depreciation and amortization (EBITDA) of 3.00 to 1.00 (3.25 to 1.00 for the 12 months following a qualified acquisition), and (b) a minimum ratio of consolidated EBITDA to consolidated interest expense (net of cash interest income) of 4.50 to 1.00. As of October 2, 2020, we had a ratio of total consolidated indebtedness to EBITDA of 0.99 to 1.00 and a ratio of consolidated EBITDA to consolidated interest expense of 12.60 to 1.00. We were in compliance with all covenants related to the Amended Credit Facilities as of October 2, 2020.

    Interest Rates and Fees. Outstanding borrowings under the Amended Credit Facilities accrue interest, at our option, at a per annum rate of (i) LIBOR plus the applicable margin, which ranges from 1.75% to 2.50% depending on the leverage ratio, or (ii) a base rate plus the applicable margin, which ranges from 0.75% to 1.50% depending on the leverage ratio. The interest rate under the Amended Credit Facilities at October 2, 2020 was 2.15%.

    Carrying Value and Fair Value. As of October 2, 2020 and December 31, 2019, the fair value of the Amended Credit Facilities approximated the carrying value because the debt bears interest at a floating rate of interest. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt.

XML

Derivative Instruments

9 Months Ended

Oct. 02, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

DERIVATIVE INSTRUMENTS

    During the periods covered by this report, we have made no changes to our policies or strategies for the use of derivative instruments and there has been no change in our related accounting methods. For our derivative instruments, which are designated as cash flow hedges, gains and losses are initially reported as a component of accumulated other comprehensive loss and subsequently recognized in earnings with the corresponding hedged item.

Interest Rate Derivative Instruments

    Our interest rate swaps are designated and qualify as effective cash flow hedges. The contracts, with expiration dates through November 2022 and notional amounts totaling $49.6 million at October 2, 2020, are recorded at fair value.

    The following table summarizes the amount at fair value and location of the derivative instruments in our balance sheet for our interest rate hedges in the Condensed Consolidated Balance Sheets as of October 2, 2020:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Interest rate swap designated as cash flow hedge	Other accrued liabilities	$	1,037
Interest rate swap designated as cash flow hedge	Other non-current liabilities	$	1,007

    The following table summarizes the amount at fair value and location of the derivative instruments used for our interest rate hedges in the Condensed Consolidated Balance Sheets as of December 31, 2019:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Interest rate swap designated as cash flow hedge	Other accrued liabilities	$	323
Interest rate swap designated as cash flow hedge	Other non-current liabilities	$	686

    We regularly assess the creditworthiness of the counterparty. As of October 2, 2020, the counterparty to the interest rate swaps had performed in accordance with its contractual obligations. Both the counterparty credit risk and our credit risk were considered in the fair value determination.

    Net interest rate derivative losses of $0.7 million and net interest rate derivative gains of less than $0.1 million were recognized in interest expense, net in our Condensed Consolidated Statements of Income during the first three quarters of 2020 and 2019, respectively. We expect $1.0 million of existing interest rate swap losses reported in accumulated other comprehensive loss as of October 2, 2020 to be recognized in earnings within the next 12 months.

Foreign Currency Derivative Instruments

    The following table summarizes the amount at fair value and location of the derivative instruments used for our forward contract hedges in the Condensed Consolidated Balance Sheets as of October 2, 2020:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Foreign currency forward designated as cash flow hedge	Other current assets	$	197
Foreign currency forward designated as cash flow hedge	Other accrued liabilities	$	44

    The following table summarizes the amount at fair value and location of the derivative instruments used for our forward contract hedges in the Condensed Consolidated Balance Sheets as of December 31, 2019:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Foreign currency forward designated as cash flow hedge	Other accrued liabilities	$	185

    At October 2, 2020, we had outstanding foreign currency forward contracts, for the exchange of U.S. dollars and Euros, with a notional amount of $9.5 million and expiration dates through September 2021.

    Counterparty default risk is considered low because the forward contracts that we entered into are over-the-counter instruments transacted with highly-rated financial institutions. We were not required to, and did not, post collateral as of October 2, 2020.

    Net foreign currency derivative losses of $0.2 million and $0.4 million were recognized in selling, general and administrative expenses during the first three quarters of 2020 and 2019, respectively. We expect $0.2 million of existing

foreign currency forward contract gains reported in accumulated other comprehensive loss as of October 2, 2020 to be recognized in earnings within the next 12 months.

XML

Leases

9 Months Ended

Oct. 02, 2020

Leases [Abstract]

Leases

Leases

    We determine whether an arrangement contains a lease at inception. We have operating leases for office space, apartments, vehicles, and machinery and equipment. Our operating leases have lease terms of less than one year to ten years.

    We do not separate lease components from non-lease components (e.g., common area maintenance, property taxes and insurance) but account for both components in a contract as a single lease component.

    The components of lease expense are as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 2, 2020		September 27, 2019		October 2, 2020		September 27, 2019
Operating lease expense	$	1,349	$	3,827	$	5,621	$	10,890
Variable lease expense	191		196		546		594
Short-term lease expense	14,323		12,436		40,483		35,055
Total lease expense	$	15,863	$	16,459	$	46,650	$	46,539

    Supplemental balance sheet information related to our operating leases is as follows:

(In thousands)	October 2, 2020		December 31, 2019
Right-of-use assets	$	9,970	$	14,654
Current lease liabilities (recorded in other accrued liabilities)	$	3,449	$	5,743
Long-term lease liabilities (recorded in other non-current liabilities)	7,553		9,811
Total operating lease liabilities	$	11,002	$	15,554

    Additional right-of-use assets of $1.5 million were recognized as non-cash asset additions that resulted from new operating lease liabilities during the first nine months of 2020.

    The weighted average remaining lease term and discount rate for our operating leases at October 2, 2020 were 5.2 years and 6.3%, respectively.

    Maturities of lease liabilities at October 2, 2020 were as follows:

(In thousands)	Payments due
2020 (excluding the nine months ended October 2, 2020)	$	4,014
2021	2,002
2022	1,720
2023	1,483
2024	1,226
2025 and beyond	2,843
Total lease payments	13,288
Less: Imputed interest	(2,286)
Total operating lease liabilities	$	11,002

XML

Stock-Based Compensation

Aug. 11, 2020

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

STOCK-BASED COMPENSATION

    We maintain an equity incentive plan (the 2014 Omnibus Plan) to govern awards granted to Vectrus employees and directors, including nonqualified stock options (NQOs), restricted stock units (RSUs), total shareholder return (TSR) awards and other awards. We account for NQOs and stock-settled RSUs as equity-based compensation awards. TSR awards, described below, and cash-settled RSUs are accounted for as liability-based compensation awards and are revalued at the end of each reporting period to reflect changes in fair value.

    Stock-based compensation expense and the associated tax benefits impacting our Condensed Consolidated Statements of Income were as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 2, 2020		September 27, 2019		October 2, 2020		September 27, 2019
Compensation costs for equity-based awards	$	1,284	$	1,124	$	4,286	$	3,339
Compensation costs for liability-based awards	(196)		798		2,213		2,613
Total compensation costs, pre-tax	$	1,088	$	1,922	$	6,499	$	5,952
Future tax benefit	$	235	$	416	$	1,404	$	1,288

    As of October 2, 2020, total unrecognized compensation costs related to equity-based awards and liability-based awards were $6.7 million and $3.3 million, respectively, which are expected to be recognized ratably over a weighted average period of 1.68 years and 1.96 years, respectively.

    The following table provides a summary of the activities for NQOs and RSUs for the nine months ended October 2, 2020:

	NQOs			RSUs
(In thousands, except per share data)	Shares	Weighted Average Exercise Price Per Share		Shares	Weighted Average Grant Date Fair Value Per Share
Outstanding at January 1, 2020	77	$	23.30	301	$	30.30
Granted	—	$	—	129	$	51.98
Exercised	(3)	$	21.43	—	$	—
Vested	—	$	—	(147)	$	30.55
Issued in exchange	—	$	—	16	$	52.28
Cancelled in exchange	—	$	—	(16)	$	29.00
Forfeited or expired	—	$	—	(18)	$	40.67
Outstanding at October 2, 2020	74	$	23.37	265	$	41.41

    During the nine months ended October 2, 2020, we granted long term incentive awards to employees consisting of 108,490 RSUs with a weighted average grant date fair value per share of $52.76 and to our directors consisting of 20,311 RSUs with a weighted average grant date fair value per share of $47.76.

    On August 11, 2020, our total outstanding 15,839 CRSUs were exchanged for 15,839 RSUs. As of the exchange date, both the CRSUs and RSUs had the same vesting conditions, fair value of $52.28, and unrecognized compensation expense of $0.4 million.

    For employee RSUs, one-third of the award vests on each of the three anniversary dates following the grant date. Director RSUs are granted on the date of an annual meeting of shareholders and vest on the business day immediately prior to the next annual meeting. The fair value of each RSU grant was determined based on the closing price of Vectrus common stock on the date of grant. Stock compensation expense will be recognized ratably over the vesting period of the awards.

Total Shareholder Return Awards

    TSR awards are performance-based cash awards that are subject to a three-year performance period. Any payments earned are made in cash following completion of the performance period according to the achievement of specified performance goals. During the nine months ended October 2, 2020, we granted TSR awards with an aggregate target TSR value of $3.1 million. The fair value of TSR awards is measured quarterly and is based on the Company’s performance relative to the performance of the Aerospace and Defense Companies in the S&P 1500 Index. Depending on the Company’s performance during the three-year performance period, payments can range from 0% to 200% of the target value.

XML

Commitments and Contingencies

9 Months Ended

Oct. 02, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

General

    From time to time, we are involved in legal proceedings that are incidental to the operation of our business. Some of these proceedings seek remedies relating to employment matters, matters in connection with our contracts and matters arising under laws relating to the protection of the environment. Additionally, U.S. Government customers periodically advise the Company of claims and penalties concerning certain potential disallowed costs. When such findings are presented, Vectrus and the U.S. Government representatives engage in discussions to enable Vectrus to evaluate the merits of these claims as well as to assess the amounts being claimed. Where appropriate, provisions are made to reflect probable losses related to the matters raised by the U.S. Government representatives. Such assessments, along with any assessments regarding provisions for legal proceedings, are reviewed on a quarterly basis for sufficiency based on the most recent information available to us. We have estimated and accrued $11.6 million and $12.1 million as of October 2, 2020 and December 31, 2019, respectively, in "Other accrued liabilities" in the Condensed Consolidated Balance Sheets for legal proceedings and for claims with respect to our government contracts as discussed below, including open years subject to audit. Although the ultimate outcome of any legal matter or claim cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claim, we do not expect that any asserted or unasserted legal or contractual claims or proceedings, individually or in the aggregate, including the lawsuit discussed below, will have a material adverse effect on our cash flow, results of operations or financial condition.

U.S. Government Contracts, Investigations and Claims

    We have U.S. Government contracts that are funded incrementally on a year-to-year basis. Changes in government policies, priorities or funding levels through agency or program budget reductions by the U.S. Congress or executive agencies could have a material adverse effect on our financial condition or results of operations. Furthermore, our contracts with the U.S. Government may be terminated or suspended by the U.S. Government at any time, with or without cause. Such contract suspensions or terminations could result in unreimbursable expenses or charges or otherwise adversely affect our financial condition and results of operations.

    Departments and agencies of the U.S. Government have the authority to investigate various transactions and operations of the Company, and the results of such investigations may lead to administrative, civil or criminal proceedings, the ultimate outcome of which could be fines, penalties, repayments or compensatory or treble damages. U.S. Government regulations provide that certain findings against a contractor may lead to suspension or debarment from future U.S. Government contracts or the loss of export privileges for a company or an operating division or subdivision. Suspension or debarment could have a material adverse effect on the Company because of its reliance on U.S. Government contracts.

    U.S. Government agencies, including the Defense Contract Audit Agency, the Defense Contract Management Agency and others, routinely audit and review our performance on government contracts, indirect rates and pricing practices, and compliance with applicable contracting and procurement laws, regulations and standards. Accordingly, costs billed or billable to U.S. Government customers are subject to potential adjustment upon audit by such agencies. The U.S. Government agencies also review the adequacy of our compliance with government standards for our business systems, including our accounting, earned value management, estimating, materials management and accounting, purchasing, and property management systems.

    As a result of final indirect rate negotiations between the U.S. Government and our Former Parent, we may be subject to potential adjustments to costs previously allocated by our Former Parent to our business, which was formerly Exelis’ Mission Systems Business, from 2007 through 2014. We are in discussions with our Former Parent regarding the negotiated adjustments from 2007-2014 and believe that our potential cumulative liability for these years is insignificant. In June 2019, the U.S. Government provided us with the Contracting Officers Final Decision (COFD) for the years 2007-2010 related to Former Parent costs. In August 2019, we filed an appeal of the COFD with the Armed Services Board of Contract Appeals (ASBCA). Since October 2019, the ASBCA has granted Vectrus’ and the U.S. Government’s joint requests to stay proceedings in the appeal, most recently through January 11, 2021, to enable ongoing discussions regarding the matter between Vectrus and our Former Parent. In June 2020, the U.S. Government provided us with the COFD for 2013 related to Former Parent costs. In September 2020, we filed an appeal of this COFD to the ASBCA and sought a deferral of payment. In addition, we filed a motion to consolidate both appeals. The ASBCA granted our motion to consolidate. We believe we are fully indemnified under our Distribution Agreement with our Former Parent and have notified our Former Parent of our appeal of the U.S governments decision in this matter.

COVID-19 Pandemic

    On March 11, 2020, the World Health Organization designated the outbreak of COVID-19 as a global pandemic. Governments and businesses around the world have taken unprecedented actions to mitigate the spread of COVID-19, including, but not limited to, shelter-in-place orders, quarantines, significant restrictions on travel, social distancing guidelines, and restrictions on employees going to work. Uncertainty with respect to the economic impacts of the pandemic has introduced significant volatility in the financial markets. The Company has observed some disruptions on its operations due to

government delays related to the global pandemic. While the extent to which COVID-19 ultimately impacts the Company’s future results will depend on future developments, the pandemic and associated economic impacts could result in a material impact to the Company’s future financial condition, results of operations and cash flows.

XML

Description of Business and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Oct. 02, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Our Business and Basis of Presentation

Our Business

    Vectrus, Inc. is a leading provider of services to the United States Government (U.S. Government) worldwide. The Company operates as one segment and provides the following services and offerings: facility and base operations; supply chain and logistics services; information technology mission support; and engineering and digital technology services.

    Vectrus was incorporated in the State of Indiana on February 4, 2014. On September 27, 2014, Exelis Inc. (Exelis) completed a spin-off (the Spin-off) of Vectrus, and Vectrus became an independent, publicly traded company.

Basis of Presentation

    Our quarterly financial periods end on the Friday closest to the last day of the calendar quarter (October 2, 2020 for the third quarter of 2020 and September 27, 2019 for the third quarter of 2019), except for the last quarter of the fiscal year, which ends on December 31. For ease of presentation, the quarterly financial statements included herein are described as three months ended.

    The unaudited interim Condensed Consolidated Financial Statements of Vectrus have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been omitted. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019.

    It is management’s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the Company’s financial position and operating results. Revenue and net income for any interim period are not necessarily indicative of future or annual results.

Accounting Standards Issued But Not Yet Effective and Accounting Standards That Were Adopted

Accounting Standards Issued but Not Yet Effective

    In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes (ASU 2019-12). The objectives of ASU 2019-12 are (i) to simplify the accounting for income taxes by removing certain exceptions, (ii) to update certain requirements to simplify the accounting for income taxes, and (iii) to make minor codification improvements for income taxes. The guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the adoption of this standard to have a material impact on the Company’s financial statements.

Accounting Standards That Were Adopted

    In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) (ASU 2018-15). The objective of ASU 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with those incurred to develop or obtain internal-use software. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The amendments can be applied either retrospectively or prospectively. We adopted ASU 2018-15 on January 1, 2020 using the retrospective method. As a result of the adoption, $0.3 million was reclassified from 2019 year-end property, plant and equipment, net, to other non-current assets on our Condensed Consolidated Balance Sheet. In addition, $0.3 million of cash outflows from investing activities incurred during the third and fourth quarters of 2019 was reclassified to cash outflows from operating activities.

    In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (ASU 2017-04). The objective of ASU 2017-04 is to simplify the subsequent measurement of goodwill by entities performing their annual goodwill impairment tests by comparing the fair value of a reporting unit, including income tax effects from any tax-deductible goodwill, with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds fair value. ASU 2017-04 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2017-04 should be applied on a prospective basis. We adopted ASU 2017-04 on January 1, 2020.  The adoption of the standard did not have a material impact on our financial statements.    

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with more useful information about the expected credit losses

on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. We adopted the standard on January 1, 2020. The adoption of the standard did not have a material impact on our financial statements.

XML

Description of Business and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Oct. 02, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

The effects of the corrections to each of the individual affected line items in our Condensed Consolidated Statements of Income were as follows:

	Three Months Ended September 27, 2019						Nine Months Ended September 27, 2019
(In thousands, except per share data)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Revenue	$	359,854	$	19	$	359,873	$	1,017,371	$	(3)	$	1,017,368
Cost of revenue	325,537		1,986		327,523		921,685		1,986		923,671
Operating income	14,383		(1,967)		12,416		35,989		(1,989)		34,000
Income from operations before income taxes	12,476		(1,967)		10,509		31,178		(1,989)		29,189
Income tax expense	3,094		(426)		2,668		7,088		(431)		6,657
Net income	$	9,382	$	(1,541)	$	7,841	$	24,090	$	(1,558)	$	22,532
Earnings per share
Basic	$	0.82	$	(0.14)	$	0.68	$	2.11	$	(0.14)	$	1.97
Diluted	$	0.80	$	(0.13)	$	0.67	$	2.08	$	(0.13)	$	1.95

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Comprehensive Income were as follows:

	Three Months Ended September 27, 2019						Nine Months Ended September 27, 2019
(In thousands)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Net income	$	9,382	$	(1,541)	$	7,841	$	24,090	$	(1,558)	$	22,532
Total comprehensive income	$	7,535	$	(1,541)	$	5,994	$	20,737	$	(1,558)	$	19,179

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Balance Sheet were as follows:

	December 31, 2019
(In thousands)	As Previously Reported		Correction		As Corrected
Receivables	$	269,239	$	(95)	$	269,144
Total current assets	320,711		(95)		320,616
Total Assets	636,484		(95)		636,389
Other accrued liabilities	34,587		2,822		37,409
Total current liabilities	242,257		2,822		245,079
Deferred tax liability	49,808		(401)		49,407
Total non-current liabilities	132,846		(401)		132,445
Total Liabilities	375,103		2,421		377,524
Retained earnings	187,591		(2,516)		185,075
Total shareholders' equity	261,381		(2,516)		258,865
Total Liabilities and Shareholders' Equity	$	636,484	$	(95)	$	636,389

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Cash Flows were as follows:

	Nine Months Ended September 27, 2019
(In thousands)	As Previously Reported		Correction		As Corrected
Net income	$	24,090	$	(1,558)	$	22,532
Changes in receivables	(7,521)		(19)		(7,540)
Changes in deferred taxes	(4,240)		(430)		(4,670)
Changes in other liabilities	7,781		2,007		9,788
Net cash provided in operating activities	$	28,448	$	—	$	28,448

    The effects of the corrections to each of the individual affected line items on our Condensed Consolidated Statements of Changes in Shareholders' Equity were as follows:

	Retained Earnings						Total Shareholders' Equity
(In thousands)	As Previously Reported		Correction		As Corrected		As Previously Reported		Correction		As Corrected
Balance at December 31, 2018	$	152,616	$	(976)	$	151,640	$	221,300	$	(976)	$	220,324
Net income	7,091		(17)		7,074		7,091		(17)		7,074
Balance at March 29, 2019	159,966		(993)		158,973		228,244		(993)		227,251
Net income	7,617		—		7,617		7,617		—		7,617
Balance at June 28, 2019	167,583		(993)		166,590		239,676		(993)		238,683
Net income	9,382		(1,541)		7,841		9,382		(1,541)		7,841
Balance at September 27, 2019	$	176,965	$	(2,534)	$	174,431	$	248,335	$	(2,534)	$	245,801

XML

Revenue (Tables)

9 Months Ended

Oct. 02, 2020

Revenue from Contract with Customer [Abstract]

Remaining Performance Obligation

Remaining performance obligations as of October 2, 2020 and December 31, 2019 are presented in the following table:

	October 2,		December 31,
(In thousands)	2020		2019
Performance Obligations	$	1,155,742	$	849,389

Disaggregation of Revenue

The following tables present our revenue disaggregated by several categories. Revenue by contract type for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Cost-plus and cost-reimbursable ¹	$	249,484	$	272,810	(8.6)	%	$	748,543	$	781,024	(4.2)	%
Firm-fixed-price	102,931		87,063		18.2	%	291,669		236,344		23.4	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368
¹ Includes time and material contracts

    Revenue by geographic region in which the contract is performed for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Middle East	$	224,934	$	244,142	(7.9)	%	$	679,633	$	695,626	(2.3)	%
United States	89,400		77,228		15.8	%	254,640		219,512		16.0	%
Europe	38,081		38,503		(1.1)	%	105,939		102,230		3.6	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

    Revenue by contract relationship for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2,		September 27,		%		October 2,		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Prime contractor	$	332,564	$	334,402	(0.5)	%	$	980,301	$	954,191	2.7	%
Subcontractor	19,851		25,471		(22.1)	%	59,911		63,177		(5.2)	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

    Revenue by customer for the three and nine months ended October 2, 2020 and September 27, 2019 is as follows:

	Three Months Ended						Nine Months Ended
	October 2.		September 27,		%		October 2.		September 27,		%
(In thousands)	2020		2019		Change		2020		2019		Change
Army	$	236,267	$	245,817	(3.9)	%	$	711,173	$	698,377	1.8	%
Air Force	79,425		86,576		(8.3)	%	231,088		227,100		1.8	%
Navy	18,785		13,344		40.8	%	48,564		45,227		7.4	%
Other	17,938		14,136		26.9	%	49,387		46,664		5.8	%
Total revenue	$	352,415	$	359,873			$	1,040,212	$	1,017,368

XML

Acquisitions (Tables)

9 Months Ended

Oct. 02, 2020

Business Combinations [Abstract]

Purchase Price Allocation

A breakdown of the purchase price allocation, net of cash acquired, is as follows:

(In thousands)	Allocation of Purchase Price
Receivables	$	11,388
Other current assets	2,719
Property, plant and equipment	155
Goodwill	28,511
Intangible assets	8,300
Other non-current assets	1,868
Accounts payable	(4,223)
Other current liabilities	(1,519)
Accrued compensation	(907)
Other non-current liabilities	(1,218)
Purchase price, net of cash acquired	$	45,074

XML

Goodwill and Intangible Assets (Tables)

9 Months Ended

Oct. 02, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Identifiable Intangible Assets

Identifiable intangible assets consist of the following:

	October 2, 2020						December 31, 2019
(In thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Contract backlogs and recompetes	$	11,600	$	(6,053)	$	5,547	$	11,600	$	(4,300)	$	7,300
Customer contracts	7,200		(1,773)		5,427		7,200		(692)		6,508
Trade names and other	1,243		(315)		928		1,236		(118)		1,118
Balance	$	20,043	$	(8,141)	$	11,902	$	20,036	$	(5,110)	$	14,926

Schedule of Amortization Expense

The estimated amortization expense for the next five years is as follows (in thousands):

Period	Amortization
2020 (excluding the nine months ended October 2, 2020)	$	998
2021	$	4,029
2022	$	2,501
2023	$	2,404
2024	$	1,297
After 2024	$	673

XML

Earnings Per Share (Tables)

9 Months Ended

Oct. 02, 2020

Earnings Per Share [Abstract]

Reconciliation of Basic and Diluted Weighted Average Shares Outstanding

	Three Months Ended				Nine Months Ended
	October 2,		September 27,		October 2,		September 27,
(In thousands, except per share data)	2020		2019		2020		2019
Net income	$	10,391	$	7,841	$	20,170	$	22,532
Weighted average common shares outstanding	11,621		11,506		11,590		11,420
Add: Dilutive impact of stock options	34		37		38		45
Add: Dilutive impact of restricted stock units	96		135		115		101
Diluted weighted average common shares outstanding	11,751		11,678		11,743		11,566
Earnings per share
Basic	$	0.89	$	0.68	$	1.74	$	1.97
Diluted	$	0.88	$	0.67	$	1.72	$	1.95

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table provides a summary of securities that could potentially dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented:

	Three Months Ended		Nine Months Ended
	October 2,	September 27,	October 2,	September 27,
(In thousands)	2020	2019	2020	2019
Anti-dilutive stock options	—	—	—	1
Anti-dilutive restricted stock units	3	—	2	3
Total	3	—	2	4

XML

Receivables (Tables)

9 Months Ended

Oct. 02, 2020

Receivables [Abstract]

Schedule of Receivables

Receivables were comprised of the following:

(In thousands)	October 2, 2020		December 31, 2019
Billed receivables	$	59,445	$	71,068
Unbilled receivables (contract assets)	199,301		186,365
Other	9,397		11,711
Total receivables	$	268,143	$	269,144

XML

Debt (Tables)

9 Months Ended

Oct. 02, 2020

Debt Disclosure [Abstract]

Schedule of Maturities of Long-term Debt

The aggregate scheduled maturities of the Amended Term Loan, are as follows:

(In thousands)	Payments due
2020 (excluding the nine months ended October 2, 2020)	$	2,000
2021	8,600
2022	55,400
Total	$	66,000

XML

Derivative Instruments (Tables)

9 Months Ended

Oct. 02, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Liabilities at Fair Value

The following table summarizes the amount at fair value and location of the derivative instruments in our balance sheet for our interest rate hedges in the Condensed Consolidated Balance Sheets as of October 2, 2020:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Interest rate swap designated as cash flow hedge	Other accrued liabilities	$	1,037
Interest rate swap designated as cash flow hedge	Other non-current liabilities	$	1,007

    The following table summarizes the amount at fair value and location of the derivative instruments used for our interest rate hedges in the Condensed Consolidated Balance Sheets as of December 31, 2019:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Interest rate swap designated as cash flow hedge	Other accrued liabilities	$	323
Interest rate swap designated as cash flow hedge	Other non-current liabilities	$	686

Schedule of Foreign Exchange Contracts, Statement of Financial Position

The following table summarizes the amount at fair value and location of the derivative instruments used for our forward contract hedges in the Condensed Consolidated Balance Sheets as of October 2, 2020:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Foreign currency forward designated as cash flow hedge	Other current assets	$	197
Foreign currency forward designated as cash flow hedge	Other accrued liabilities	$	44

Schedule of Notional Amounts of Outstanding Derivative Positions

The following table summarizes the amount at fair value and location of the derivative instruments used for our forward contract hedges in the Condensed Consolidated Balance Sheets as of December 31, 2019:

(In thousands)	Fair Value
	Balance sheet caption	Amount
Foreign currency forward designated as cash flow hedge	Other accrued liabilities	$	185

XML

Leases (Tables)

9 Months Ended

Oct. 02, 2020

Leases [Abstract]

Components of lease expense

The components of lease expense are as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 2, 2020		September 27, 2019		October 2, 2020		September 27, 2019
Operating lease expense	$	1,349	$	3,827	$	5,621	$	10,890
Variable lease expense	191		196		546		594
Short-term lease expense	14,323		12,436		40,483		35,055
Total lease expense	$	15,863	$	16,459	$	46,650	$	46,539

Balance sheet information related to leases

Supplemental balance sheet information related to our operating leases is as follows:

(In thousands)	October 2, 2020		December 31, 2019
Right-of-use assets	$	9,970	$	14,654
Current lease liabilities (recorded in other accrued liabilities)	$	3,449	$	5,743
Long-term lease liabilities (recorded in other non-current liabilities)	7,553		9,811
Total operating lease liabilities	$	11,002	$	15,554

Maturity of lease liabilities

Maturities of lease liabilities at October 2, 2020 were as follows:

(In thousands)	Payments due
2020 (excluding the nine months ended October 2, 2020)	$	4,014
2021	2,002
2022	1,720
2023	1,483
2024	1,226
2025 and beyond	2,843
Total lease payments	13,288
Less: Imputed interest	(2,286)
Total operating lease liabilities	$	11,002

XML

Stock-Based Compensation (Tables)

9 Months Ended

Oct. 02, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Impact of Stock-Based Compensation in Consolidation and Combined Statements of Income

Stock-based compensation expense and the associated tax benefits impacting our Condensed Consolidated Statements of Income were as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 2, 2020		September 27, 2019		October 2, 2020		September 27, 2019
Compensation costs for equity-based awards	$	1,284	$	1,124	$	4,286	$	3,339
Compensation costs for liability-based awards	(196)		798		2,213		2,613
Total compensation costs, pre-tax	$	1,088	$	1,922	$	6,499	$	5,952
Future tax benefit	$	235	$	416	$	1,404	$	1,288

Schedule of Non-Qualified Stock Options, Activity

The following table provides a summary of the activities for NQOs and RSUs for the nine months ended October 2, 2020:

	NQOs			RSUs
(In thousands, except per share data)	Shares	Weighted Average Exercise Price Per Share		Shares	Weighted Average Grant Date Fair Value Per Share
Outstanding at January 1, 2020	77	$	23.30	301	$	30.30
Granted	—	$	—	129	$	51.98
Exercised	(3)	$	21.43	—	$	—
Vested	—	$	—	(147)	$	30.55
Issued in exchange	—	$	—	16	$	52.28
Cancelled in exchange	—	$	—	(16)	$	29.00
Forfeited or expired	—	$	—	(18)	$	40.67
Outstanding at October 2, 2020	74	$	23.37	265	$	41.41

XML

Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)	9 Months Ended
	Oct. 02, 2020 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	1
Number of operating segments	1

XML

Description of Business and Summary of Significant Accounting Policies - Immaterial Restatement of Prior Period Balances (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended							9 Months Ended		12 Months Ended
	Oct. 02, 2020	Jul. 03, 2020	Apr. 03, 2020	Dec. 31, 2019	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Decrease in retained earnings	$ (205,245)			$ (185,075)				$ (205,245)		$ (185,075)
Net income	$ (10,391)	$ (1,111)	$ (8,668)		$ (7,841)	$ (7,617)	$ (7,074)	$ (20,170)	$ (22,532)
Decrease in diluted earnings per share (in dollars per share)	$ (0.88)				$ (0.67)			$ (1.72)	$ (1.95)
Correction
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Decrease in retained earnings				$ 2,516						2,516
Net income					$ 1,541	$ 0	$ 17		$ 1,558	$ 1,500
Decrease in diluted earnings per share (in dollars per share)				$ 0.00	$ 0.13	$ 0.00	$ 0.00		$ 0.13	$ 0.13	$ 0.02	$ 0.01

XML

Description of Business and Summary of Significant Accounting Policies - Condensed Consolidated Statements of Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended							9 Months Ended		12 Months Ended
	Oct. 02, 2020	Jul. 03, 2020	Apr. 03, 2020	Dec. 31, 2019	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue	$ 352,415				$ 359,873			$ 1,040,212	$ 1,017,368
Cost of revenue	320,234				327,523			951,743	923,671
Operating income	14,837				12,416			29,751	34,000
Income from operations before income taxes	13,898				10,509			25,763	29,189
Income tax expense	3,507				2,668			5,593	6,657
Net income	$ 10,391	$ 1,111	$ 8,668		$ 7,841	$ 7,617	$ 7,074	$ 20,170	$ 22,532
Earnings per share
Basic (in dollars per share)	$ 0.89				$ 0.68			$ 1.74	$ 1.97
Diluted (in dollars per share)	$ 0.88				$ 0.67			$ 1.72	$ 1.95
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue					$ 359,854				$ 1,017,371
Cost of revenue					325,537				921,685
Operating income					14,383				35,989
Income from operations before income taxes					12,476				31,178
Income tax expense					3,094				7,088
Net income					$ 9,382	7,617	7,091		$ 24,090
Earnings per share
Basic (in dollars per share)					$ 0.82				$ 2.11
Diluted (in dollars per share)					$ 0.80				$ 2.08
Correction
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue					$ 19				$ (3)
Cost of revenue					1,986				1,986
Operating income					(1,967)				(1,989)
Income from operations before income taxes					(1,967)				(1,989)
Income tax expense					(426)				(431)
Net income					$ (1,541)	$ 0	$ (17)		$ (1,558)	$ (1,500)
Earnings per share
Basic (in dollars per share)					$ (0.14)				$ (0.14)
Diluted (in dollars per share)				$ (0.00)	$ (0.13)	$ (0.00)	$ (0.00)		$ (0.13)	$ (0.13)	$ (0.02)	$ (0.01)

XML

Description of Business and Summary of Significant Accounting Policies - Condensed Consolidated Statements of Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Oct. 02, 2020	Jul. 03, 2020	Apr. 03, 2020	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income	$ 10,391	$ 1,111	$ 8,668	$ 7,841	$ 7,617	$ 7,074	$ 20,170	$ 22,532
Total comprehensive income	$ 12,725			5,994			$ 22,107	19,179
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income				9,382	7,617	7,091		24,090
Total comprehensive income				7,535				20,737
Correction
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income				(1,541)	$ 0	$ (17)		(1,558)	$ (1,500)
Total comprehensive income				$ (1,541)				$ (1,558)

XML

Description of Business and Summary of Significant Accounting Policies - Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Oct. 02, 2020	Jul. 03, 2020	Apr. 03, 2020	Dec. 31, 2019	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Dec. 31, 2018
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Receivables	$ 268,143			$ 269,144
Total current assets	356,414			320,616
Total Assets	665,928			636,389
Other accrued liabilities	38,572			37,409
Total current liabilities	247,246			245,079
Deferred tax liability	41,734			49,407
Total non-current liabilities	134,877			132,445
Total Liabilities	382,123			377,524
Retained earnings	205,245			185,075
Total shareholders' equity	283,805	$ 269,435	$ 264,243	258,865	$ 245,801	$ 238,683	$ 227,251	$ 220,324
Total Liabilities and Shareholders' Equity	$ 665,928			636,389
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Receivables				269,239
Total current assets				320,711
Total Assets				636,484
Other accrued liabilities				34,587
Total current liabilities				242,257
Deferred tax liability				49,808
Total non-current liabilities				132,846
Total Liabilities				375,103
Retained earnings				187,591
Total shareholders' equity				261,381	248,335	239,676	228,244	221,300
Total Liabilities and Shareholders' Equity				636,484
Correction
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Receivables				(95)
Total current assets				(95)
Total Assets				(95)
Other accrued liabilities				2,822
Total current liabilities				2,822
Deferred tax liability				(401)
Total non-current liabilities				(401)
Total Liabilities				2,421
Retained earnings				(2,516)
Total shareholders' equity				(2,516)	$ (2,534)	$ (993)	$ (993)	$ (976)
Total Liabilities and Shareholders' Equity				$ (95)

XML

Description of Business and Summary of Significant Accounting Policies - Condensed Consolidated Statement of Cash Flow (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Oct. 02, 2020	Jul. 03, 2020	Apr. 03, 2020	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income	$ 10,391	$ 1,111	$ 8,668	$ 7,841	$ 7,617	$ 7,074	$ 20,170	$ 22,532
Changes in receivables							3,584	(7,540)
Changes in deferred taxes							(7,575)	(4,670)
Changes in other liabilities							18,597	9,788
Net cash provided in operating activities							$ 37,655	28,448
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income				9,382	7,617	7,091		24,090
Changes in receivables								(7,521)
Changes in deferred taxes								(4,240)
Changes in other liabilities								7,781
Net cash provided in operating activities								28,448
Correction
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income				$ (1,541)	$ 0	$ (17)		(1,558)	$ (1,500)
Changes in receivables								(19)
Changes in deferred taxes								(430)
Changes in other liabilities								2,007
Net cash provided in operating activities								$ 0

XML

Description of Business and Summary of Significant Accounting Policies - Condensed Consolidated Statements of Changes in Shareholders' Equity (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Oct. 02, 2020	Jul. 03, 2020	Apr. 03, 2020	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Balance	$ 269,435	$ 264,243	$ 258,865	$ 238,683	$ 227,251	$ 220,324	$ 258,865	$ 220,324	$ 220,324
Net income	10,391	1,111	8,668	7,841	7,617	7,074	20,170	22,532
Balance	283,805	269,435	264,243	245,801	238,683	227,251	283,805	245,801	258,865
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Balance			261,381	239,676	228,244	221,300	261,381	221,300	221,300
Net income				9,382	7,617	7,091		24,090
Balance				248,335	239,676	228,244		248,335	261,381
Correction
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Balance			(2,516)	(993)	(993)	(976)	(2,516)	(976)	(976)
Net income				(1,541)	0	(17)		(1,558)	(1,500)
Balance				(2,534)	(993)	(993)		(2,534)	(2,516)
Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Balance	194,854	193,743	185,075	166,590	158,973	151,640	185,075	151,640	151,640
Net income	10,391	1,111	8,668	7,841	7,617	7,074
Balance	$ 205,245	$ 194,854	$ 193,743	174,431	166,590	158,973	$ 205,245	174,431	185,075
Retained Earnings | As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Balance				167,583	159,966	152,616		152,616	152,616
Net income				9,382	7,617	7,091
Balance				176,965	167,583	159,966		176,965
Retained Earnings | Correction
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Balance				(993)	(993)	(976)		(976)	$ (976)
Net income				(1,541)	0	(17)
Balance				$ (2,534)	$ (993)	$ (993)		$ (2,534)

XML

Recent Accounting Standards Update - Additional Information (Details) - USD ($) $ in Thousands		9 Months Ended		12 Months Ended
	Jan. 01, 2020	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2018	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accounting Standards Update [Extensible List]		us-gaap:AccountingStandardsUpdate201815Member		us-gaap:AccountingStandardsUpdate201802Member
Property, plant, and equipment, net		$ (19,256)			$ (18,844)
Other non-current assets		6,256			$ 5,366
Cash outflows from investing activities		(3,348)	$ (53,003)
Cash outflows from operating activities		$ (37,655)	$ (28,448)
Revision of Prior Period
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Property, plant, and equipment, net	$ 300
Other non-current assets	300
Cash outflows from investing activities	300
Cash outflows from operating activities	$ 300

XML

Revenue - Revenue Performance Obligations (Details) - USD ($)	9 Months Ended
	Oct. 02, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Performance obligations timing	The Company's contracts are multi-year contracts and typically include an initial period of one year or less with annual one-year (or less) option periods
Increase in remaining performance obligations	$ 306,400,000
Performance Obligations	$ 1,155,742,000	$ 849,389,000

XML

Revenue - Revenue Performance Obligations (Percentage and Remaining Period of Time) (Details)	Oct. 02, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-03
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	30.00%
Revenue, expected performance obligation, period	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	70.00%
Revenue, expected performance obligation, period	1 year

XML

Revenue - Revenue Contract Estimates (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Revenue from Contract with Customer [Abstract]
Favorable adjustments to operating income	$ 0.1	$ 0.7		$ 1.5
Unfavorable adjustments to operating income			$ 3.8
Unfavorable adjustment to revenue	$ 1.1		$ 0.5
Favorable adjustment to revenue		$ 4.0		$ 4.2

XML

Revenue - Revenue by Contract Type (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 352,415	$ 359,873	$ 1,040,212	$ 1,017,368
Cost-plus and cost-reimbursable
Disaggregation of Revenue [Line Items]
Total revenue	$ 249,484	272,810	$ 748,543	781,024
Revenue, percent change	(8.60%)		(4.20%)
Firm-fixed-price
Disaggregation of Revenue [Line Items]
Total revenue	$ 102,931	$ 87,063	$ 291,669	$ 236,344
Revenue, percent change	18.20%		23.40%

XML

Revenue - Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 352,415	$ 359,873	$ 1,040,212	$ 1,017,368
Middle East
Disaggregation of Revenue [Line Items]
Total revenue	$ 224,934	244,142	679,633	$ 695,626
Revenue, percent change	(7.90%)			(2.30%)
United States
Disaggregation of Revenue [Line Items]
Total revenue	$ 89,400	77,228	254,640	$ 219,512
Revenue, percent change	15.80%			16.00%
Europe
Disaggregation of Revenue [Line Items]
Total revenue	$ 38,081	$ 38,503	$ 105,939	$ 102,230
Revenue, percent change	(1.10%)			3.60%

XML

Revenue - Revenue by Contract Relationship (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 352,415	$ 359,873	$ 1,040,212	$ 1,017,368
Prime contractor
Disaggregation of Revenue [Line Items]
Total revenue	$ 332,564	334,402	980,301	$ 954,191
Revenue, percent change	(0.50%)			2.70%
Subcontractor
Disaggregation of Revenue [Line Items]
Total revenue	$ 19,851	$ 25,471	$ 59,911	$ 63,177
Revenue, percent change	(22.10%)			(5.20%)

XML

Revenue - Revenue by Customer (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 352,415	$ 359,873	$ 1,040,212	$ 1,017,368
Army
Disaggregation of Revenue [Line Items]
Total revenue	$ 236,267	245,817	711,173	$ 698,377
Revenue, percent change	(3.90%)			1.80%
Air Force
Disaggregation of Revenue [Line Items]
Total revenue	$ 79,425	86,576	231,088	$ 227,100
Revenue, percent change	(8.30%)			1.80%
Navy
Disaggregation of Revenue [Line Items]
Total revenue	$ 18,785	13,344	48,564	$ 45,227
Revenue, percent change	40.80%			7.40%
Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 17,938	$ 14,136	$ 49,387	$ 46,664
Revenue, percent change	26.90%			5.80%

XML

Revenue - Revenue Contract Balances (Details) - USD ($) $ in Millions	Oct. 02, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Contract assets	$ 199.3	$ 186.4

XML

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	$ 3,507	$ 2,668	$ 5,593	$ 6,657
Effective income tax rate	25.20%	25.40%	21.70%	22.80%
Unrecognized tax benefits	$ 12,500		$ 12,500		$ 7,900

XML

Acquisitions - Additional Information (Details) $ in Thousands		3 Months Ended		9 Months Ended
	Jul. 08, 2019 USD ($) intangibleAsset	Oct. 02, 2020 USD ($)	Sep. 27, 2019 USD ($)	Oct. 02, 2020 USD ($)	Sep. 27, 2019 USD ($)	Dec. 31, 2019 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition of business, net of cash acquired				$ 0	$ 43,963
Amortization expense		$ 1,000	$ 800	3,031	$ 2,103
Goodwill		$ 262,130		$ 262,130		$ 261,983
Advantor
Acquired Finite-Lived Intangible Assets [Line Items]
Consideration transferred	$ 45,100
Acquisition of business, net of cash acquired	44,000
Working capital adjustments	$ 1,100
Number of intangible assets | intangibleAsset	2
Weighted average amortization period				3 years 8 months 12 days
Amortization expense				$ 1,300
Goodwill	$ 28,511
Advantor | Customer contracts
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets	$ 7,200
Amortization period	5 years
Advantor | Trade name
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets	$ 1,100
Amortization period	4 years 6 months

XML

Acquisitions - Business Acquisition (Details) - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019	Jul. 08, 2019
Business Acquisition [Line Items]
Goodwill	$ 262,130	$ 261,983
Advantor
Business Acquisition [Line Items]
Receivables			$ 11,388
Other current assets			2,719
Property, plant and equipment			155
Goodwill			28,511
Intangible assets			8,300
Other non-current assets			1,868
Accounts payable			(4,223)
Other current liabilities			(1,519)
Accrued compensation			(907)
Other non-current liabilities			(1,218)
Purchase price, net of cash acquired			$ 45,074

XML

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019	Dec. 31, 2019	Jul. 08, 2019
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill	$ 262,130		$ 262,130		$ 261,983
Amortization expense	$ 1,000	$ 800	$ 3,031	$ 2,103
Remaining average life intangible assets			3 years 7 months 6 days
Advantor
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill						$ 28,511
Increase in purchase price allocation			$ 100
Amortization expense			$ 1,300

XML

Goodwill and Intangible Assets - Schedule of Identifiable Assets (Details) - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 20,043	$ 20,036
Accumulated Amortization	(8,141)	(5,110)
Net Carrying Amount	11,902	14,926
Contract backlogs and recompetes
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	11,600	11,600
Accumulated Amortization	(6,053)	(4,300)
Net Carrying Amount	5,547	7,300
Customer contracts
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	7,200	7,200
Accumulated Amortization	(1,773)	(692)
Net Carrying Amount	5,427	6,508
Trade names and other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,243	1,236
Accumulated Amortization	(315)	(118)
Net Carrying Amount	$ 928	$ 1,118

XML

Goodwill and Intangible Assets - Amortization Expense (Details) $ in Thousands	Oct. 02, 2020 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020 (excluding the nine months ended October 2, 2020)	$ 998
2021	4,029
2022	2,501
2023	2,404
2024	1,297
After 2024	$ 673

XML

Earnings Per Share - Reconciliation of Basic and Diluted Weighted Average Shares Outstanding (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 02, 2020	Jul. 03, 2020	Apr. 03, 2020	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Oct. 02, 2020	Sep. 27, 2019
Earnings Per Share [Abstract]
Net income	$ 10,391	$ 1,111	$ 8,668	$ 7,841	$ 7,617	$ 7,074	$ 20,170	$ 22,532
Weighted average common shares outstanding (in shares)	11,621			11,506			11,590	11,420
Add: Dilutive impact of stock options (in shares)	34			37			38	45
Add: Dilutive impact of restricted stock units (in shares)	96			135			115	101
Diluted weighted average common shares outstanding (in shares)	11,751			11,678			11,743	11,566
Earnings per share
Basic (in dollars per share)	$ 0.89			$ 0.68			$ 1.74	$ 1.97
Diluted (in dollars per share)	$ 0.88			$ 0.67			$ 1.72	$ 1.95

XML

Earnings Per Share - Anti-dilutive Options (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive stock options (in shares)	3	0	2	4
Anti-dilutive stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive stock options (in shares)	0	0	0	1
Anti-dilutive restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive stock options (in shares)	3	0	2	3

XML

Receivables - Schedule of Receivables (Details) - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019
Receivables [Abstract]
Billed receivables	$ 59,445	$ 71,068
Unbilled receivables (contract assets)	199,301	186,365
Other	9,397	11,711
Total receivables	$ 268,143	$ 269,144

XML

Receivables - Narrative (Details) $ in Millions	Oct. 02, 2020 USD ($)
Receivables [Abstract]
Unbilled receivables, allowance for credit loss	$ 6.1

XML

Debt - Additional Information (Details)	1 Months Ended	9 Months Ended
	Nov. 30, 2017 USD ($)	Oct. 02, 2020 USD ($) letters_of_credit
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 100,000,000.0
Increase limit	100,000,000.0
Letters of credit
Debt Instrument [Line Items]
Number of letters of credit outstanding | letters_of_credit		2
Letters of credit outstanding		$ 2,400,000
Remaining borrowing capacity		$ 117,600,000
Senior secured credit facilities
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	200,000,000.0
Covenant terms, ratio of total indebtedness to combined EBITDA		3.00
Covenant terms, maximum debt to EBITDA ratio, twelve months following purchase		3.25
Covenant terms, ratio of EBITDA to interest expense, net,		4.50
Ratio of total indebtedness to combined EBITDA		0.99
Ratio of combined EBITDA to combined interest expense		12.60
Interest rate		2.15%
Senior secured credit facilities | London Interbank Offered Rate (LIBOR) | Minimum
Debt Instrument [Line Items]
Spread on variable rate		1.75%
Senior secured credit facilities | London Interbank Offered Rate (LIBOR) | Maximum
Debt Instrument [Line Items]
Spread on variable rate		2.50%
Senior secured credit facilities | Base Rate | Minimum
Debt Instrument [Line Items]
Spread on variable rate		0.75%
Senior secured credit facilities | Base Rate | Maximum
Debt Instrument [Line Items]
Spread on variable rate		1.50%
Term facility
Debt Instrument [Line Items]
Debt outstanding		$ 66,000,000
Term facility | Line of Credit
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 80,000,000.0
Debt instrument, term	5 years
Revolver | Line of Credit
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 120,000,000.0
Debt instrument, term	5 years
Debt outstanding		$ 0
Unsecured Debt
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 75,000,000.0
Amended revolver | Line of Credit
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 25,000,000.0

XML

Debt - Schedule of Maturities (Details) - Term facility $ in Thousands	Oct. 02, 2020 USD ($)
Payments due
2020 (excluding the nine months ended October 2, 2020)	$ 2,000
2021	8,600
2022	55,400
Total	$ 66,000

XML

Derivative Instruments - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019
Interest Rate Swap
Derivative [Line Items]
Gain (loss) on foreign currency forward contracts recognized in accumulated other comprehensive income (loss)	$ (1.0)
Foreign Currency Forward Contracts
Derivative [Line Items]
Gain (loss) on derivative instruments, net, pretax	(0.2)	$ (0.4)
Gain (loss) on foreign currency forward contracts recognized in accumulated other comprehensive income (loss)	0.2
Cash Flow Hedging | Interest Rate Swap | Designated as hedging instrument
Derivative [Line Items]
Derivative, notional amount	49.6
Gain (loss) on derivative instruments, net, pretax	(0.7)	$ 0.1
Cash Flow Hedging | Foreign Currency Forward Contracts | Designated as hedging instrument
Derivative [Line Items]
Derivative, notional amount	$ 9.5

XML

Derivative Instruments - Interest Rate Hedges in the Condensed Consolidated Balance Sheets (Details) - Cash Flow Hedging - Designated as hedging instrument - Interest Rate Swap - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019
Other accrued liabilities
Derivative [Line Items]
Interest rate swap designated as cash flow hedge, liability	$ 1,037	$ 323
Other non-current liabilities
Derivative [Line Items]
Interest rate swap designated as cash flow hedge, liability	$ 1,007	$ 686

XML

Derivative Instruments - Forward Contract Hedges in the Consolidated Condensed Balance Sheets (Details) - Cash Flow Hedging - Designated as hedging instrument - Foreign Currency Forward Contracts - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019
Other current assets
Derivative [Line Items]
Foreign currency forward designated as cash flow hedge, liability	$ 197
Other accrued liabilities
Derivative [Line Items]
Foreign currency forward designated as cash flow hedge, liability	$ 44	$ 185

XML

Leases - Additional Information (Details) $ in Millions	9 Months Ended
	Oct. 02, 2020 USD ($)
Lessee, Lease, Description [Line Items]
Right-of-use assets resulting from new operating lease liabilities	$ 1.5
Weighted average remaining lease term	5 years 2 months 12 days
Weighted average remaining discount rate	6.30%
Minimum
Lessee, Lease, Description [Line Items]
Operating lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease terms	10 years

XML

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Leases [Abstract]
Operating lease expense	$ 1,349	$ 3,827	$ 5,621	$ 10,890
Variable lease expense	191	196	546	594
Short-term lease expense	14,323	12,436	40,483	35,055
Total lease expense	$ 15,863	$ 16,459	$ 46,650	$ 46,539

XML

Leases - Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019
Leases [Abstract]
Right-of-use assets	$ 9,970	$ 14,654
Current lease liabilities (recorded in other accrued liabilities)	3,449	5,743
Long-term lease liabilities (recorded in other non-current liabilities)	7,553	9,811
Total operating lease liabilities	$ 11,002	$ 15,554
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent	us-gaap:AccruedLiabilitiesCurrent
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	us-gaap:OtherLiabilitiesNoncurrent	us-gaap:OtherLiabilitiesNoncurrent

XML

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Oct. 02, 2020	Dec. 31, 2019
Leases [Abstract]
2020 (excluding the nine months ended October 2, 2020)	$ 4,014
2021	2,002
2022	1,720
2023	1,483
2024	1,226
2025 and beyond	2,843
Total lease payments	13,288
Less: Imputed interest	(2,286)
Total operating lease liabilities	$ 11,002	$ 15,554

XML

Stock-Based Compensation - Schedule of Impact of Stock-Based Compensation in Condensed Consolidated Statements of Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2020	Sep. 27, 2019	Oct. 02, 2020	Sep. 27, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation cost for awards	$ 1,088	$ 1,922	$ 6,499	$ 5,952
Future tax benefit	235	416	1,404	1,288
Compensation costs for equity-based awards
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation cost for awards	1,284	1,124	4,286	3,339
Compensation costs for liability-based awards
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation cost for awards	$ (196)	$ 798	$ 2,213	$ 2,613

XML

Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions		9 Months Ended
	Aug. 11, 2020	Oct. 02, 2020	Dec. 31, 2019
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs	$ 0.4
Granted (in shares)		129,000
Granted (in dollars per share)		$ 51.98
Outstanding (in shares)		265,000	301,000
Issued in exchange (in shares)	15,839	16,000
Issued in exchange (in dollars per share)	$ 52.28	$ 52.28
Outstanding (in dollars per share)		$ 41.41	$ 30.30
RSUs | Share-based Compensation Award, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting increments		33.33%
RSUs | Share-based Compensation Award, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting increments		33.33%
RSUs | Share-based Compensation Award, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting increments		33.33%
CRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs	$ 0.4
Outstanding (in shares)	15,839
Outstanding (in dollars per share)	$ 52.28
Total Shareholder Return Awards (TSR)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		3 years
Aggregate award target value		$ 3.1
Minimum | Total Shareholder Return Awards (TSR)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return award target		0.00%
Maximum | Total Shareholder Return Awards (TSR)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return award target		200.00%
Employees | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		108,490
Granted (in dollars per share)		$ 52.76
Director | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		20,311
Granted (in dollars per share)		$ 47.76
Equity Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs		$ 6.7
Unrecognized compensation costs, period for recognition		1 year 8 months 4 days
Liability Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs		$ 3.3
Unrecognized compensation costs, period for recognition		1 year 11 months 15 days

XML

Stock-Based Compensation - Schedule of Non-Qualified Stock Options, Activity (Details) - $ / shares		9 Months Ended
	Aug. 11, 2020	Oct. 02, 2020
NQOs
NQOs, Shares
Outstanding at beginning of period (in shares)		77,000
Exercised (in shares)		(3,000)
Outstanding at end of period (in shares)		74,000
NQOs, Weighted Average Exercise Price Per Share
Outstanding at beginning of period (in dollars per share)		$ 23.30
Exercised (in dollars per share)		21.43
Outstanding at end of period (in dollars per share)		$ 23.37
RSUs
RSUs, Shares
Outstanding at beginning of period (in shares)		301,000
Granted (in shares)		129,000
Vested (in shares)		(147,000)
Issued in exchange (in shares)	15,839	16,000
Cancelled in exchange (in shares)		(16,000)
Forfeited or expired (in shares)		(18,000)
Outstanding at end of period (in shares)		265,000
RSUs, Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share)		$ 30.30
Granted (in dollars per share)		51.98
Vested (in dollars per share)		30.55
Issued in exchange (in dollars per share)	$ 52.28	52.28
Cancelled in exchange (in dollars per share)		29.00
Forfeited or expired (in dollars per share)		40.67
Outstanding at beginning of period (in dollars per share)		$ 41.41

XML

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	Oct. 02, 2020	Dec. 31, 2019
Contract compliance
Loss Contingencies [Line Items]
Contracts loss contingency accrual	$ 11.6	$ 12.1